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THE METASTASIS SUPPRESSOR NM23-H1 IS REQUIRED FOR DNA REPAIR 
 
        NM23-H1 represents the first identified metastasis suppressor, exhibiting 
reduced expression in breast carcinoma and melanoma, and an ability to inhibit 
metastatic growth without significant impact on the transformed phenotype. 
Although its molecular mechanism of action is not fully understood, NM23-H1 
possesses at least three enzymatic activities that may mediate metastasis 
suppressor function. It catalyzes nucleoside diphosphate kinase (NDPK) activity, 
as well as protein histidine kinase and 3’-5’ exonuclease activities. As 3’-5’ 
exonucleases are generally required for maintenance of genomic integrity, this 
activity represents a plausible mediator to underlie the metastasis suppressor 
function of NM23-H1 protein. To investigate the relevant activity of NM23-H1 in 
metastasis suppression, we constructed a panel of NM23-H1 mutant variants with 
selective enzymatic lesions. Previous studies have identified some key amino 
acid residues important for the enzymatic characteristics of NM23-H1. However, 
none of them are selective for disrupting the 3’-5’ exonuclease activity. In this 
study, we show that a substitution of Glu5 to alanine results in a dramatic, 
selective loss in 3’-5’ exonuclease property without significant affecting other 
enzymatic activities. To measure the extent to which the exonuclease function 
opposes mutation and metastasis, NM23-deficient and metastatic cell lines with 
forced expression of NM23-H1 variants are analyzed in nude mice. In 
spontaneous metastasis models, NM23-H1 mutants deficient in 3‘-5’ exonuclease 
activity significantly disrupt the capacity of metastasis suppression of wild-type 
protein, indicating that the 3’-5’ exonuclease activity of NM23-H1 is necessary for 
the spontaneous metastasis-suppressing effects. As 3'-5' exonucleases are 
generally associated with DNA repair process, we have also studied the 
contributions of yeast NM23 homologue YNK1 to genomic integrity in 
Saccharomyces cerevisiae. Consistent with an antimutator function, ablation of 
YNK1 significantly results in increased mutation rates following exposure to UV 
irradiation and the alkylating agent methyl methanesulfonate (MMS). The 
impaired DNA-damage response of ynk1∆ cells suggests a role of human 
homologue NM23 in DNA repair. More evidence is being collected in our 
laboratory to demonstrate a role for NM23-H1 in maintaining genomic integrity. 
Collectively, our findings of DNA repair activity of NM23-H1 will contribute to the 
understandings of the mechanisms in metastasis suppression and new drug 
discoveries. 
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CHAPTER ONE 
INTRODUCTION 
 
1.1. Cancer Metastasis Progression and Genomic Instability 
 
        Tumor metastases arise from the spread of cancer cells from a primary 
site and form the colonization in distant organs. Most invasive, malignant 
tumors give rise to tumor metastases by a multi-step process as shown in 
Figure 1, in which primary cells lose cellular adhesion, increase motility, 
invade surrounding tissues, disseminate through the bloodstream to distant 
organs, and proliferate in new locations (Chambers et al., 2002). Each step 
must be successfully completed to give rise to a metastatic tumor. Tumor 
metastases, instead of primary tumors, are the cause of 90% of human 
cancer deaths (Sporn, 1996). To prevent these deaths, better understanding 
of the processes and mechanisms of tumor invasion and metastasis is 
essential to identify promising molecular targets for cancer therapy. 
        Metastasis is an inefficient process, by which millions of cells might be 
released by a tumor into the circulation, but only a tiny minority of these cells 
will colonize at a distant organ (Siclari et al., 2006). In vivo microscopy and 
cell-fate analysis have showed that some steps (e.g., invasion and metastatic 
colonization) of the metastatic process are more inefficient than some other 
steps (e.g., cells survival in the circulation, arrest in a distant organ and initial 
extravasation) (Chambers et al., 2002). Metastatic inefficiency is primarily due 
to the regulation of cancer cell growth in secondary sites. However, due to 
their genetic instability and heterogeneity, tumors do have a distinct chance to 
overcome incompatible microenvironments. During tumor progression, many 
genes gain or lose function allowing a cancer cell to acquire the prerequisites 
for metastasis such as altered cell adhesion, limitless replication, increased 
motility and invasion, and anchorage independent growth (Nguyen and 
Massague, 2007). 
        Progression of cancer from a less malignant to a more malignant  
phenotype is well-accepted to be due to inherent genomic instability (Loeb, 
1991, 2001). The accumulated genetic and epigenetic changes lead to an 
increasingly aggressive and treatment-resistant phenotype, and ultimately 
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metastasis. This idea is supported by evidence that highly metastatic clones 
from tumor-cell populations had higher mutation rates than non-metastatic 
clones from the same tumor. For example, spontaneous mutation rates to 
ouabain resistance measured in six human melanoma cell lines by Luria and 
Delbrück using fluctuation analysis correlated with the metastatic ability of the 
cells: moderately and highly metastatic cells showed spontaneous mutation 
rates 10 to 50 times higher than those of poorly metastatic cells (Bailly et al., 
1993). These results provided a direct link between metastasis and genetic 
instability.  
.  
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Figure 1. Metastasis is a complex, multistep process.  
 
                           Picture from 2003 Nature Reviews Cancer 3, 55 - 63  
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1.2. NM23 is a Metastasis Suppressor  
 
        Metastasis suppressors, by definition, repress metastasis without 
affecting primary tumor growth. The concept of tumor suppressor prompted 
the identification of metastasis suppressors, which were found to exhibit 
reduced expression in highly metastatic tumors or cell lines compared to that 
of non-metastatic tumor cells (Steeg, 2003). Some other metastasis 
suppressor genes were cloned when chromosomes or portions of 
chromosomes were transfected into cell lines and a decrease in metastatic 
potential was observed. So far, thirteen metastasis suppressor genes have 
been confirmed (Palmieri et al., 2006). The entire panel of metastasis 
suppressor genes were validated by re-expression in a metastatic cell line, 
resulting in inhibition of in vivo metastasis without significant effect on 
tumorigenicity as compared to controls (Steeg, 2003). 
        Metastasis suppressors often affect many aspects of signal transduction 
pathways including invasion, growth-factor-receptor signaling, the mitogen-
activated protein kinase pathway, cell-cell communication and transcription 
(Steeg, 2003). For instance, KAI1, a metastasis-suppressor for prostate and 
breast carcinomas (Dong et al., 1996; Yang et al., 1997), belonging to a 
tetraspanin family of transmembrane proteins, is directly associated with the 
EGF receptor and attenuates EGF-induced migration signaling (Odintsova et 
al., 2000).  MKK4, another metastasis-suppressor for prostate and ovary 
cancer, transduced signals from MEKK1 to stress-activated protein 
kinase/JNK1 and p38 mitogen-activated protein kinase (Kauffman et al., 2003; 
Teng et al., 1997). By this mitogen-activated protein kinase pathway, MKK4 
regulated the signal transduction of stress-induced apoptosis in cancer (Kim 
et al., 2001; Yamada et al., 2002). 
        nm23, the first identified metastasis suppressor gene, represents the 
most widely validated metastasis suppressor gene based on transfection and 
knockout mouse strategies. Transfection of nm23-H1 or -H2 cDNAs (or their 
murine homologues -M1 or -M2) into some metastatically competent cell lines 
can reduce in vivo metastatic potential of these cell lines without significant 
effects on primary tumor formation (Palmieri et al., 2006). These observations 
were further supported by studies performed in nm23-M1 knockout mice: 
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when hepatocellular carcinoma was induced into the knockout mice, primary 
tumor size did not change significantly, whereas the incidence of metastases 
increased markedly (Boissan et al., 2005). A correlation has been established 
between low NM23 expression and high metastatic potential in multiple 
cancers, e.g., melanoma, hepatoma, breast and gastric carcinoma (Hartsough 
and Steeg, 2000). However, this correlation was absent or opposite in other 
cancers (e.g., colon carcinoma; (Myeroff and Markowitz, 1993) ), suggesting 
NM23 may play different roles in different tissues.  
        So far, nine human NM23 members (named as NM23-H1 to -H9) have 
been reported and were found in multiple subcellular compartments (Lacombe 
et al., 2000; Sadek et al., 2003). The two most abundantly expressed and the 
most widely studied, NM23-H1 and NM23-H2, are 88% identical in amino acid 
sequence. They encode the A and B isoforms of nucleoside diphosphate 
kinase (NDPK) respectively, catalyzing the transfer of a γ-phosphate between 
NTPs and NDPs via a “ping-pong” mechanism (Agarwal et al., 1978). The 
NM23/NDPK genes are highly conserved from prokaryotes to eukaryotes. In 
addition to NDPK activity, many other biochemical and biological functions 
were attributed to NM23 proteins, including histidine protein kinase activity 
(Freije et al., 1997), DNA cleavage activity (Ma et al., 2004; Postel, 1999), 
transcriptional regulation (Ma et al., 2002; Postel, 2003), and protein binding 
interactions (Salerno et al., 2003).          
        Finally, it has been reported that NM23/NDPK families play an important 
role not only in tumor metastasis but also in cell growth, differentiation, 
development and apoptosis (Lombardi et al., 2000). However, despite 
extensive studies, the whole picture of NM23 relating to its multiple functions 
is still under way. Our lab focuses on the study of the anti-metastatic 
mechanisms of NM23-H1. 
 
 
1.3. Enzymatic Activities and the Potential Anti-metastatic Mechanism(s) 
of NM23  
 
        NM23 proteins have been identified to possess multiple enzymatic 
activities, but the biological and biochemical mechanism(s) underlying its 
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ability to suppress metastasis still remain under active investigation. Figure 2 
summarizes the primary biochemical activities of NM23-H1 as understood at 
present, and highlights potential anti-metastatic functions for each.  
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Figure 2. Potential anti-metastatic functions of the primary enzymatic 
activities of NM23-H1. 
 
 
                               Picture from 2006 J. Bioenerg. Biomembr. 38:163 -167 
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1.3.1. Nucleoside diphosphate kinase (NDPK) activity  
 
        NM23 proteins have been characterized as nucleoside diphosphate 
kinases (NDPK) (Lascu et al., 2000), although not all members in the NM23 
family exhibited NDPK activity (in human, only recombinant H1, H2 and H4 
contained NDPK activity; (Yoon et al., 2005)). NDPK is a ubiquitous enzyme 
highly conserved from bacteria to human, which catalyzes the 
phosphorylation of nucleoside diphosphates to nucleoside triphosphates using 
ATP as phosphor-donor via a “ping-pong” mechanism (Agarwal et al., 1978). 
The ping-pong mechanism involves a conserved histidine as the intermediate 
where the imidazole side chain gets auto-phosphorylated.  
 
 
 
In addition, NDPK is a highly efficient enzyme with a turnover number of about 
103 s−1 and a kcat/Km of about 107 M−1 s−1, and utilizes either purine or 
pyrimidine ribo- or deoxyribonucleosides as substrates (Postel, 1998). As 
highly efficient phospho-transferases, NDPKs maintain an intracellular 
nucleotide balance for nucleic acid synthesis and other metabolic functions. 
However, the gene encoding NDPK is not essential for viability in E. coli and 
yeast (Fukuchi et al., 1993; Lu et al., 1995). Mutants of E. coli lacking ndk 
exhibited normal growth rates but showed a mutator phenotype that was 
attributed to the absence of NDPK catalytic activity or to an imbalance in 
cellular nucleotide triphosphates (Lu et al., 1995). Although it was suggested 
that the NDPK activity of NM23-H1 was not essential for suppressing the 
metastatic potential (MacDonald et al., 1993), this yet needs to be 
demonstrated using an in vivo forced expression model. 
 
1.3.2. Histidine protein kinase activity 
 
        Histidine protein kinases are well described in prokaryotes and lower 
eukaryotes, where they form the “two-component” signal transduction system. 
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The prototypical two-component regulator system is comprised of two proteins, 
a histidine protein kinase (sensor protein), which usually binds to the cell 
membrane, and a response regulator (effector protein), which is associated 
with an internal response. The sensor kinase, when activated by a signal, 
autophosphorylates at a histidine residue using ATP as a phosphor-donor. 
Then, the phosphorylated sensor kinase transfers the phosphoryl group to a 
conserved aspartate residue in the response regulator. This phosphorylation 
modulates the activity of the effector protein to elicit an adaptive response to 
the stimulus (Calera et al., 1998). Several features distinguish histidine protein 
kinases: (1) histidine is a high energy bond; (2) phosphohistidine is acid labile, 
and therefore difficult to detect in conventional gel systems; (3) histidine 
kinases form a phosphohistidine intermediate, which then transfers the 
phosphate to the substrate (Ouatas et al., 2003).  
        The histidine protein kinase activity of NM23 was reported to correlate 
with motility suppression. When wild-type and site-directed mutant (P96S and 
S120G) nm23-H1 constructs were transfected into MDA-MB-435 breast 
carcinoma cells, the P96S mutant (histidine kinase deficient) showed impaired 
motility suppression (MacDonald et al., 1996). In addition to inhibiting 
metastasis in vivo and motility in vitro by overexpression of NM23-H1, a 
diminished Map kinase activation was also found by Steeg and colleagues 
(Hartsough et al., 2002). Kinase suppressor of Ras (KSR), a scaffold protein 
for the mitogen-activated protein kinase (MAPK) cascade, was co-
immunoprecipitated with NM23-H1 from both transfected 293T cells and 
human MDA-MB-435 breast carcinoma cells. Autophosphorylated 
recombinant NM23-H1 phosphorylated KSR in vitro and serine was 
determined as the major target by phosphor-amino acid analysis. In the same 
paper, they also found that Map kinase activation was reduced in an nm23-H1 
transfected MDA-MB-435 cells. Moreover, the P96S-H1 transfectant exhibited 
relatively high levels of activated Map kinase, suggesting that the histidine 
protein kinase activity of NM23-H1 was needed for suppression of Map kinase 
activation. Therefore, it was hypothesized that overexpression of NM23-H1 
increased the KSR phosphorylation and inhibited Map kinase activation, 
which may contribute to the mechanism of metastasis suppression 
(Hartsough et al., 2002). However, the relevant downstream substrate of the 
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histidine kinase and their relationships to metastasis suppression awaits more 
detailed characterization.  
 
1.3.3. DNA binding and transcriptional regulation 
 
        NM23-H2 is recognized as the transcription factor PuF, which activates 
transcription of the c-myc gene in vitro by binding to and activating a 
nuclease-hypersensitive element (NHE) in the c-myc promoter (Berberich and 
Postel, 1995). These in vitro findings have been confirmed in living cells (e.g., 
Burkitt lymphoma cells) by cell transfection assays (Ji et al., 1995). The NHE 
contains an asymmetric pattern of repeated sequences, “GC” rich regions,  
which would form unusual structures, including “slipped DNA”, loops, triplexes, 
and G-quadruplex structures (Postel, 2003). In addition, NM23-H2/PuF is 
capable of recognizing and interacting with such unusual structural elements 
to activate the c-myc gene (Postel, 1998, 1999). 
        Later, NM23-H1 was identified as a DNA-binding protein to the platelet-
derived growth factor-A (PDGF-A) chain promoter in our laboratory (Ma et al., 
2002). The PDGF-A chain promoter is regulated by several enhancer and 
silencer elements, which are GC-rich and possess non-B DNA structures. 
NM23-H1 was identified to bind and mediate a silencer element in the 5’-
flanking sequence of the PDGF-A gene termed 5’-SHS by screening a HeLa 
cell cDNA expression library with the DNA recognition site approach.  
Transient transfection analyses in HepG2 cells revealed that both H1 and H2 
repressed transcriptional activity driven by the PDGF-A basal promoter (-82 to 
+8), another NHE element. Activity of the negative regulatory region (-1853 to 
-883), which contained the 5’-SHS, was also inhibited by H1 and H2. These 
studies demonstrated for the first time that NM23-H1 also interacted with DNA 
structurally and functionally. They also indicated a role for both NM23 proteins 
in repressing transcription of an oncogene, providing a possible molecular 
mechanism to explain their metastasis-suppressing effects.  
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1.3.4. DNA cleavage activity 
        NM23-H2 cleaved both DNA strands of a duplex oligonucleotide 
substrate comprised of the c-myc nuclease hypersensitive element (NHE), 
leaving double-stranded breaks within the repeated sequence elements 
(Postel, 1999). The breaks produced staggered ends with 5-nucleotide-long 
3’-extensions. A covalent protein-DNA complex was suggested between the 
cleaved 5’-phosphoryl ends and lysine-12 (Postel, 1999). Since covalent 
protein-DNA complexes were known to serve the roles of breaking and 
rejoining DNA strands, it was concluded that NM23-H2 was involved in DNA 
structural transactions necessary for the activity of the c-myc promoter (Postel, 
2003). Lysine-12 was identified to be the amino acid responsible for the 
covalent cleavage by NM23-H2 (Postel et al., 2000). In particular, the ε-amino 
group acted as the critical nucleophile, because substitution with glutamine 
but not arginine completely abrogated covalent adduct formation and DNA 
cleavage, whereas the DNA-binding properties remained intact (Postel et al., 
2000). These findings and chemical modification data suggested that 
phosphodiester-bond cleavage by NM23-H2 occurred via a DNA 
glycosylase/lyase-like mechanism (Postel et al., 2000), which was known as 
the signature of nucleases in base excision repair (Cunningham, 1997; 
McCullough et al., 1999). A DNA repair-like activity for NM23 would be 
consistent with its role in suppressing the metastatic progression.  
        We focused our attention on the DNA cleavage activity of NM23-H1, in 
which we demonstrated 3’-5' exonuclease activity by virtue of its ability in 
stoichiometric amounts to excise single nucleotides in a stepwise manner 
from the 3' terminus of DNA (Ma et al., 2004). The lines of evidence to support 
that the 3'-5' exonuclease activity is an intrinsic ability of NM23-H1 are: 1) 
precise coelution of enzymatic activity with NM23-H1 protein during 
purification by hydroxylapatite and gel filtration column high performance 
liquid chromatography and 2) site-specific mutation of a residue shown 
previously to inactivate the NM23-H2 isoform (K12Q) also resulted in a 
reproducible loss of 3’-5’ exonuclease activity in NM23-H1. The DNA-binding 
and 3'-5' exonuclease activity of NM23-H1 was further confirmed by 
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mutagenesis assays and NMR studies by the Pfeifer group (Yoon et al., 2005). 
Generally, 3’-5’ exonucleases play critical roles in maintaining genomic 
stability, and their loss often leads to increased mutation rates. Plus, anti-
mutator functions are commonly associated with tumor suppressors. 
Therefore, this raises the questions: does the 3’-5’ exonuclease activity of 
NM23-H1 play a role in maintaining the genomic integrity of a cell? If so, does 
this anti-mutator function mediate the metastasis suppressor activity of NM23-
H1? These important questions will be addressed in this project.  
 
 
1.4. Project Objectives 
 
        The 3’-5’ exonuclease activity is very intriguing in light of the association 
of these enzymes with DNA repair processes, and the mutator phenotypes 
often arise as a consequence of their deficiencies (Shevelev and Hubscher, 
2002). Progression to the metastatic phenotype is well-recognized to require 
the accumulation of mutations that permit tumor cells to overcome numerous 
barriers to metastatic growth. Currently, we propose that the 3’-5’ 
exonuclease activity of NM23-H1 plays an important role in maintaining 
genomic stability and in turn suppressing metastatic progression of tumor 
cells. This could be a logical candidate explanation for the anti-metastatic 
mechanism of NM23-H1. 
        To test our hypothesis, we used site-directed mutagenesis to generate a 
panel of NM23-H1 mutants in which the primary biochemical activities of the 
molecule (NDPK, histidine kinase and 3’-5’ exonuclease) have been 
individually inactivated. The metastasis suppressor activities of these variant 
NM23-H1 mutants were further analyzed by in vivo metastasis assays, in 
hopes of showing that loss of anti-metastatic function would be related to the 
inactivated biochemical activity of NM23-H1 mutant. Moreover, in an effort to 
quantify the contribution of NM23-H1 to its potential anti-mutator function, we 
initiated experiments in the yeast Saccharomyces cerevisiae. S. cerevisiae 
provides an excellent eukaryotic model for rapid and convenient analysis of 
mutation rates. The budding yeast genome has been sequenced and 
knockout strains are available for essentially all genes. To measure the extent 
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to which expression of YNK1 (NM23 homologue in S. cerevisiae) is required 
for genomic integrity in a cell, mutation rates in ynk1∆ strain were measured 
under basal conditions and genotoxic stress.  
        The overall goal of this project is to understand the physiological role of 
the 3’-5’ exonuclease activity of NM23-H1, as well as its potential relationship 
to metastasis suppressor activity. 
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CHAPTER TWO 
SITE-DIRECTED MUTAGENESIS IDENTIFIES RESIDUES NECESSARY 
FOR MUTIPLE ENZYMATIC ACTIVITIES OF THE METASTASIS 
SUPPRESSOR, NM23 
 
2.1. Introduction 
 
        nm23-H1 was the first identified metastasis suppressor gene on the 
basis of its reduced expression in highly metastatic melanoma and breast 
carcinoma cells, and an ability of forced NM23-H1 expression to inhibit 
metastatic potential without significant impact on the transformed phenotype 
(Steeg et al., 1988). The human NM23 proteins are composed of six identical 
subunits of 17-19 kDa each and assemble into hexamers as arrangement of 
“dimer of trimers”. In x-ray crystal structure, as shown in Figure 3B, each 
monomer folds into four-stranded anti-parallel β sheets surrounded by α 
helices (Morera et al., 1995; Webb et al., 1995). 
        NM23-H1 has been discovered to exhibit multiple enzymatic activities, 
but the mechanism(s) underlying its ability to suppress metastasis still remain 
controversial. First, the NDP kinase activity of NM23-H1 plays an important 
role in maintaining nucleotides balance; however, its relevance to metastasis 
suppression is still uncertain. Second, the histidine kinase activity of NM23-H1 
was reported to correlate with motility suppression. NM23-H1 mutants (e.g. 
P96S and S120G) exhibited a decreased activity in histidine-dependent protein 
phosphotransferase in vitro (Freije et al., 1997). Both mutants lacked the 
motility-suppressing capacity of the wild-type NM23-H1 when overexpressed 
in MDA-MB-435 breast carcinoma cells (MacDonald et al., 1996). However, 
the in vivo downstream substrate of the histidine kinase activity of NM23 is 
still not clear. The relevance of this activity to metastasis suppression needs 
to be examined in an animal model. Finally, NM23-H2 was able to cleave the 
internal sites within the nuclease-hypersensitive element (NHE) sequence 
(Postel, 1999), which was further characterized as DNA glycosylase/lyase-like 
mechanism, a hallmark of base excision DNA repair enzymes (Postel et al., 
2000). Moreover, our laboratory has recently identified that recombinant 
NM23-H1 possesses significant 3’-5’ exonuclease activity in vitro (Ma et al., 
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2004). Generally, enzymes that contain 3’-5’ exonuclease activity are involved 
directly in DNA repair processes and maintenance of genomic stability 
(Shevelev and Hubscher, 2002). Therefore, we hypothesized that loss of the 
3’-5’ exonuclease activity of NM23-H1 during tumor progression could 
possibly impair genomic integrity and increase mutation rates, thereby 
enhancing the metastatic potential. However, due to the multiple impacts of 
metastasis suppressor on a cell, contributions from other biochemical 
pathway to metastasis suppression also need to be considered.  
        To study the active sites for the multiple enzymatic activities of NM23-H1, 
site-directed mutagenesis was initiated in our laboratory. Previous studies in 
our laboratory identified amino acid residues important for the enzymatic 
characteristics of NM23-H1. For instance, lysine12 was necessary for both the 
cleavage and NDP kinase activities of NM23-H1; whereas histidine118, the 
NDPK catalytic site, to phenylalalnine mutation led to a total loss of NDP 
kinase activity (Ma et al., 2004). However, none were selective for disrupting 
the exonuclease activity. To test our hypothesis that the 3’-5’ exonuclease 
activity of NM23-H1 might mediate its suppressing effects on metastasis, the 
first goal was to identify a mutant selectively disrupted in the 3’-5’ 
exonuclease activity. Therefore, more amino acid residues were targeted to 
be substituted. First, the substitution of glutamine17 to asparagine (Q17N) of 
NM23-H2 identified that the necessity of residue Gln17 was only for DNA 
cleavage but not NDP kinase activity (Postel et al., 2002). Since 88% of the 
amino acid residues in the NM23-H1 protein are identical to NM23-H2, the 
similar results were expected to be exhibited in NM23-H1 based on the same 
residue substitutions. Second, the residue Glu5 was recently reported to be 
critical for DNA cleavage activity of NM23-H1 (Yoon et al., 2005). To fully 
understand the importance of this residue on the multiple enzymatic activities 
of NM23-H1, a Glu5 to alanine mutation (E5A) was introduced as part of this 
study. Third, our laboratory found the residues Tyr52 and Asp54 of NM23-H1 
are homologous with the same residues on the EXOIII domain of known 3’-5’ 
exonucleases. The EXOIII motif has been identified as the required DNA 
cleavage domain, which was highly conserved in selected 3’-5’ exonucleases 
from prokaryotic to mammalian species (Shevelev and Hubscher, 2002). 
Therefore, these two residues were believed to be important for the 
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exonuclease activity of NM23-H1 and needed to be tested. Finally, a Pro96 to 
serine (P96S) substitution was included due to its importance on histidine 
kinase activity of NM23-H1 (Freije et al., 1997). The relevance of this residue 
on the DNA cleavage activity needed to be further examined. Taken together, 
the complete generation of variant NM23-H1 mutants would provide a useful 
foundation to study the anti-metastatic function of the molecule. 
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Figure 3. The structure of NM23-H1 (A) Amino acid sequence and 
schematic representation of NM23-H1 indicating major secondary structural 
features, the α helices, β sheets and Kpn loop. The substituted amino acids 
are labeled in bold font. (B) Ribbon diagram of an NM23-H1 monomer, folding 
as four-stranded anti-parallel β sheets surrounded by α helices. (C) Space-
filling model of the NM23-H1 hexamer. Side chains of the substituted amino 
acid residues are labeled as indicated.  
A.  
 
B.  
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C. 
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2.2. Materials and Methods 
 
2.2.1. DNA and site-directed mtagenesis 
 
        cDNAs encoding the NM23-H1 mutant variants Q17N, Y52A, D54A and 
P96S were generated by the overlap extension modification of the polymerase 
chain reaction (PCR), as described (Ho et al., 1989), and were inserted in 
frame between the NdeI and BamHI sites of the E. coli expression plasmid 
pET3c (New England Biolabs). The E5A mutant was constructed using the 
QuikChange site-directed mutagenesis kit (Stratagene). The mutagenic 
primers to construct the E5A, Q17N, Y52A, D54A and P96S mutants are shown 
in Table 1 (codons encoding the mutant residue are underlined in bold font). 
The cloned PCR products were sequenced by ACGT and Elim 
Biopharmaceutical Inc. to ensure that only the desired mutation was present. 
pET3c plasmids containing wild-type NM23-H1 and the H118F mutant were 
kindly provided by E. Postel (Princeton University), while construction of K12Q 
was described previously (Ma et al., 2004). 
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Table 1. The mutagenic primers to construct the E5A, Q17N, Y52A, D54A 
and P96S mutants. Codons encoding the mutant residue are underlined in 
bold font. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NM23-H1 
mutation 
Forward mutagenic primer 
5’?3’ 
Reward  mutagenic primer 
5’?3’ 
E5A 
ATG GCC AAC TGT GCT CGT 
ACC TTC 
GAA GGT ACG AGC ACA 
GTT GGC CAT 
Q17N 
CCA GAT GGG GTC AAC 
CGG GGT CTT 
AAG ACC CCG GTT GAC 
CCC ATC TGG  
Y52A 
AAG GAA CAC GCC GTT 
GAC CTG AAG G  
C CTT CAG GTC AAC GGC 
GTG TTC CTT 
D54A 
GAA CAC TAC GTT GCC CTG 
AAG GAC CG 
CG GTC CTT CAG GGC AAC 
GTA GTG TTC 
P96S 
GAG ACC AAC TCA GCA 
GAC TCC 
GGA GTC TGC TGA GTT 
GGT CTC 
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2.2.2. Overexpression and purification of recombinant human NM23-H1 
and NM23-H2 proteins 
 
        NM23-H1 and mutant proteins were expressed and purified by our 
standard protocol as previously described (Ma et al., 2004; Ma et al., 2002). 
Briefly, pET3c vectors containing wild-type and variants of NM23-H1 were 
used to transform E. coli (BL21 plysS; Promega). For protein expression, 
freshly transformed bacteria were grown overnight at 37 °C in LB-ampicillin 
medium. Two ml of the overnight culture was used to inoculate 200 ml of LB 
medium containing ampicillin. When A600 reached 0.6, protein expression 
was induced by the addition of isopropyl-1-thio-β-D-galactopyranoside (final 
concentration of 0.4 mM). Three hours following the induction, cells were 
harvested, resuspended in 30 ml of lysis buffer (50 mM Tris, pH 8.0) 
containing 1 mM EDTA and dithiothreitol, 1 mM leupeptin and pepstatin A, 
and 0.1 mM phenylmethylsulfonyl fluoride (Sigma), and then lysed by 
sonication. Cell lysates were cleared by centrifugation at 12,000 x g for 30 min 
and proteins were precipitated with ammonium sulfate (60-90% fractions). 
The 60-90% fraction was prepared for application to a DEAE-Sephacel 
column by dialysis into 50 mM Tris buffer (pH 7.5) containing a mixture of 
protease inhibitors. Next, NM23-H1 bound to the column was eluted with a 0–
1 M NaCl gradient and peak fractions at ~350 mM NaCl were collected. Peak 
fractions containing NM23 proteins were equilibrated in 10 mM phosphate 
buffer (pH 7.0) by centrifugal filtration (Centricon-10, Millipore) and loaded 
onto a hydroxyapatite (HTP) column. NM23-H1 was eluted with an 80-ml 
phosphate gradient of 10-800 mM (pH 7.0). Purity of recombinant proteins 
was evaluated by SDS-PAGE and Commassie Blue and/or silver staining. 
NM23-H2 proteins were expressed and purified by the same procedure as 
NM23-H1 except that NM23-H2 plasmids were transformed into E. coli BL21 
strain (Promega), not BL21 plysS. 
 
2.2.3. 3’-5’ exonuclease assay 
 
        The reactions were performed as described (Ma et al., 2002) with a 
single-stranded, 33-base oligodeoxyribonucleotide substrate corresponding to 
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the noncoding strand of the 5’-SHS silencer element (5’-SHS antisense strand, 
or 5’-SHSas) from the platelet-derived growth factor A gene (Liu et al., 1996). 
5’-termini were radio-labeled in a 40-µl reaction mixture at 37 °C for 30 min 
using [γ-32P]ATP and T4 polynucleotide kinase. DNA cleavage reactions were 
conducted at ambient room temperature in a 15-µl volume containing 20 mM 
Hepes buffer (pH 7.9), 10-20 fmol of 5’-[32P]-labeled oligonucleotide, 2 mM 
MgCl2 and 100 mM KCl, and were initiated by the addition of 1 µg NM23-H1 
(640nM). Reactions were terminated by adding an equal volume of 
sequencing loading dye consisting of 80% deionized formamide (w/v), 10 mM 
EDTA (pH 8.0), xylene cyanol FF (1 mg/ml), and bromphenol blue (1 mg/ml) 
followed by heating at 95 °C for 5 min. Cleavage products were resolved on 
14% sequencing gels and visualized by phosphoimaging (Storm 860, 
Amersham Biosciences). 
 
.2.2.4. Nucleoside-diphosphate kinase assay 
 
        NDPK activity of NM23-H1 and variant mutants was measured as 
described (Agarwal et al., 1978) by a coupled pyruvate-lactate 
dehydrogenase assay in which ATP acted as a phosphate donor and dTDP 
as an acceptor. The procedure was modified for the use of 96-well plates and 
microplate reader (Ma et al., 2004). NDPK reactions were initiated by the 
addition of 10 µl of purified NM23-H1 (10-50 ng) to a 140-µl reaction mixture 
containing 1 mM pyruvate enol phosphate, 5 mM ATP, 2.5 mM dTDP, 6 mM 
MgCl2, 50 mM KCl, 1000 units of pyruvate kinase and lactate dehydrogenase 
in 100 mM Tris-HCl, pH 7.4. NAD+ formation, which reflected ADP production, 
was measured every 25 seconds at 340 nm by a HTS 7000 plus Bioassay 
Plate Reader (PerkinElmer). Specific activity was expressed as units/mg of 
protein, with 1 unit defined as the amount of enzyme converting 1 µmol of 
ADP/min at room temperature (ε340 of NADH = 6.22 x 103 M-1 cm-1). 
 
2.2.5. Circular dichroism analysis 
 
        Far UV-CD spectra were recorded from 260 to 190 nm using a Jasco J-
810 spectrometer, with each individual spectrum representing the average of 
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30 replicate measurements. Prior to analysis, purified NM23-H1 proteins were 
diluted to a concentration of 0.12 mg/ml in 5 mM phosphate buffer (pH 7.0) 
(ε280 = 1.35 for a 1 mg/ml solution; (Lascu et al., 1997)). CD spectra were 
recorded at 5 °C in a quartz cuvette with a 0.1-cm path-length. CD data were 
converted to mean residual ellipticity, assuming a hexameric structure and 
mean residue molecular mass of 113 Da, the latter calculated from a 152-
amino acid monomer with a molecular mass of 17,180 Da (Rosengard et al., 
1989). Secondary structure estimates were derived from the 250–190 nm 
region of the recorded CD spectra using the programs CONTILL, SELCON3, 
and CDSSTR and their reference set of 43 proteins (Sreerama and Woody, 
2000) from CDPro software package (lamar.colostate/edu~sreeram/CDPro/). 
 
2.2.6. High performance liquid chromatography (HPLC) gel filtration 
 
        Purified wild-type or mutant variants of NM23-H1 were analyzed as 
described (Ma et al., 2004). Briefly, proteins were loaded on a Shodex gel 
filtration HPLC column (Shodex Protein KW-800, Showa Denko) pre-
equilibrated in 50 mM Tris-HCl (pH 7.5), 0.1 M KCl. Molecular weights of 
NM23-H1 were estimated relative to a standard curve generated with a 
commercially available molecular mass standards kit (Sigma) containing 
cytochrome C (12.4 kDa), carbonic anhydrase (29 kDa), bovine serum 
albumin (66 kDa), alcohol dehydrogenase (150 kDa), β-amylase (200 kDa), 
and blue dextran (2,000 kDa). 
 
 
2.3. Results 
 
2.3.1. DNA sequencing verified only the desired mutations present 
 
        The site of the substituted amino acids in the sequence of NM23-H1 is 
indicated in Figure 3, panel A and C. The cloned PCR products were 
sequenced by sense and anti-sense strands to ensure that only the desired 
mutation was present (Figure 4). 
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Figure 4. Sequence verification of PCR-generated cDNAs of NM23-H1 
mutants. Double strands of cloned NM23-H1 DNA were sequenced to verify 
that only the desired substitution was present. The substituted nucleotides 
were underlined in the histogram profile. (A) E5A-H1 (B) Q17N-H1 (C) Y52A-H1 
(D) D54A-H1 (E) P96S-H1 
A.         E(gag)?A(gct) 
    
 
 
 
 
 
 
B.                    Q(cag)?N(aac) 
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C.                   Y(tac)?A(gcc) 
 
 
 
 
 
 
 
D.   D(gac)?A(gcc) 
 
 
 
 
 
 
        
E.                   P(cct)?S(tca) 
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2.3.2. Recombinant NM23-H1 and NM23-H2 proteins were overexpressed 
and purified 
 
        NM23-H1 variants were purified with a three-step protocol consisting of 
ammonium sulfate precipitation and sequential chromatographic steps of 
DEAE-Sephacel and hydroxylapatite. Compared to the elution time of wild-
type NM23-H1 (82-83 min, Figure 5, panel A) from the hydroxylapatite column, 
the P96S mutant (Figure 5, panel E) was eluted slightly earlier (81-82 min); the 
Y52A mutant (Figure 5, panel D) was eluted much earlier (69-70 min); the E5A 
mutant (Figure 5, panel B) was eluted slightly later (84-85 min); while The 
Q17N was eluted at the same position of the phosphate gradient as the wild-
type protein (Figure 5, panel C, 82-83 min), 
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Figure 5. Hydroxylapatite column chromatography of wild-type and 
mutant NM23-H1. Figures shown below are elution profiles from the final step 
of purification involving HTP column chromatography. HTP chromatography 
was conducted using a Waters HPLC system at a flow rate of 1 ml/min, with 
NM23-H1 proteins eluted using an 80-ml gradient of potassium phosphate 
(10–800 mM, pH 7.0) and the collection of 1-min fractions. Within each of 
panels A–E, A280 profile (top) and analysis of column fractions by SDS-
PAGE gel with Coomassie staining (bottom) are shown. The elution time of 
the NM23-H1 variants from the HTP column are (A) 82-83 min for wild-type 
H1. (B) 84-85 min for E5A-H1. (C) 82-83 min for Q17N-H1.  (D) 69-70 min for 
Y52A-H1. (E) 81-82 min for P96S-H1. 
 
A. 
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B.  
 
 
 
 
 
 
 
 
 
 
C.  
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D.  
 
 
 
 
 
 
 
 
 
 
E.  
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2.3.3. 3’-5’ Exonuclease activity of NM23-H1 mutants was measured 
 
        To assess the effects of these amino acid substitutions on DNA cleavage 
activity, 1 µg of wild-type or mutant NM23-H1 protein was incubated with 10–
20 fmol of 5’-[32P]-labeled 5’-SHSas oligodeoxyribonucleotide at 22 °C during 
a 1-hour time course (5, 10, 15, 20, 40, 60min) in the presence of 2 mM 
MgCl2 and 100 mM KCl. Cleavage products were analyzed by electrophoresis 
through denaturing 14% polyacrylamide gel and visualized by 
phosphorimaging. Wild-type NM23-H1 elicited the rapid appearance of 
products representing progressive removal of single nucleotides from the 3’ 
terminus with increasing incubation time (Figure 6A, lanes 2-7). 60 minutes of 
incubation yielded substantial DNA fragments ranging between 15 and 17 nt 
(Figure 6A, lane 7). The Q17N and P96S mutants produced very similar 
cleavage activity as the wild-type H1, presenting time-dependent appearance 
of progressive single nucleotide digestion from 3’ terminus to 5’ terminus on 
the single strand DNA substrate (Figure 6A, lanes 8-13 and 14-19, 
respectively). The Y52A mutant generated less digested fragments than the 
wild-type protein, while still yielding a considerable quantity of the 15–33-nt 
series of fragments (Figure 6A, lanes 20-25). Digestion by the E5A mutant are 
significantly reduced, evidenced by much slower rate of depletion of the full-
length substrate (Figure 6A, lanes 26-31). The results of cleavage activity of 
the E5A, Q17N, Y52A and P96S mutants were consistently seen with three or 
more replicate preparations of each protein. The diminished 3’-5’ exonuclease 
activity of the E5A mutant indicated a potential role for Glu5 in the catalytic 
mechanism. Therefore, besides Lys12, a critical site of DNA cleavage activity 
as previous reported (Ma et al., 2004), Glu5 is another amino acid residue 
important for 3’-5’ exonuclease activity of NM23-H1. 
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Figure 6. 3’-5’ exonuclease activity of purified NM23-H1 mutants. A, 1 µg 
of wild-type (WT) or mutant (Q17N, P96S, Y52A, E5A) NM23-H1 protein was 
incubated with 10 fmol of 32P-labeled 5’-SHS-AS oligodeoxynucleotide under 
standard cleavage assay conditions during the indicated time. B, Cleaved 
products were quantified by phosphorimaging to derive the cleaved amount of 
nucleotides.   
A.  
 
 
 
 
 
 
 
 
B. 
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2.3.4. NDPK activity of NM23-H1 mutants was measured 
 
        NDPK activity was measured using a coupled pyruvate kinase/lactate 
dehydrogenase assay as described previously (Agarwal et al., 1978; Ma et al., 
2004). The average specific NDPK activity of wild-type NM23-H1 was 630 
units/mg. Compared to this, the E5A and Q17N mutants retained 70-80% 
NDPK activity of the wild-type (440 units/mg and 520 units/mg, respectively, 
Table 2), consistent with the effect of Q17N-H2 mutant on this kinase activity 
(Postel et al., 2002). The NDPK activity of the P96S mutant was 127 units/mg 
(Table 2), not consistent with a previous report, in which it was shown the 
P96S-H1 mutant retained full NDPK activity (Freije et al., 1997). However, this 
inconsistency is not surprising, because the Freije group used a different 
method from the one we used. They determined the formation of [γ-32P]GTP 
from non-radioactive GDP when incubated with [γ-32P]ATP and NM23-H1. 
However, the method we used was to quantify the specific activity of the 
enzyme, which was more accurate and reliable. Finally, the NDPK activity of 
Y52A mutant was dramatically inhibited (below the detection limits; Table 2), 
indicating Y52 was likely to play a critical role in the NDPK activity of NM23-H1.   
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Table 2. NDPK, histidine kinase and 3’-5’ exonuclease activities for 
NM23-H1 variants.  
 
NDPK Histidine Kinase 3’-5’ Exonuclease Protein 
 activity
1
 
% of 
WT activity
2
 
% of 
WT activity
3
 
% of 
WT 
WT   627 ± 36e 100 9.9 100    28.4 ± 4.0 100 
E5A   438 ± 31
d 70 8.2 83     3.4 ± 1.5* 12 
K12Q    14 ± 0.9
b,4 2 0.9 9      5.2 ± 3.5* 18 
Q17N   516 ± 10
d 82 6.5 66 31.4 ± 6.0 110 
Y52A B.D.
a
 0 0.4 4 25.3 ± 3.9 89 
P96S   127 ± 5
c 20 1.1 11 24.9 ± 5.1 88 
H118F B.D.
a,4
 0   B.D. 0 33.0 ± 9.0 116  
 
1NDPK activity is expressed as the mean ± S.E. in units/mg proteins, derived 
from at least three different protein preparations.   
2Histidine kinase activity is expressed as a percent of substrate converted per 
minute. (Assays performed by Robert McCorkle.) 
3Exonuclease activity is expressed in fmol/5min (mean ± S.E.) and is derived 
from at least three assays conducted with at least three independent protein 
preparations.   
4Values shown for NDPK activity of K12Q and H118F were published previously 
(Ma et al., 2004). 
a-d Means not showing a common superscript are significantly different (p ≤ 
0.01). 
*Means bearing an asterisk within a column are significantly different (p ≤ 
0.05). 
B.D., below detection. 
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2.3.5. Oligomeric structure of NM23-H1 mutants was not significantly 
changed based on molecular weight estimates  
 
        The purified mutant NM23-H1 variant proteins were further analyzed by 
gel filtration HPLC to estimate oligomeric structure and molecular weight. Two 
peaks were observed with wild-type NM23-H1 protein (Figure 7), a primary 
peak at approximately 18.74 min with an estimated molecular mass of 87.7 
kDa (Table 3) and a minor peak at about 17.1 min. Our previous evidence 
showed that the DNA cleavage activity precisely coeluted with the primary 
peak of oligomerized NM23-H1 protein (Ma et al., 2004), suggesting the minor 
peak could be some nonspecific copurified contaminants. The primary peak of 
NM23-H1 mutants was observed at 18.78(E5A), 18.76(Q17N), 18.90(Y52A) and 
18.79(P96S) minute, respectively. Molecular weight estimates obtained by gel 
filtration HPLC for E5A, Q17N and P96S were not significantly different from 
that of wild-type NM23-H1 (Table 3). Y52A exhibited a small, but statistically 
significant decrease (9 kDa) in apparent size. However, this small decrease 
was not consistent with an effect on oligomeric structure and was possibly 
due to anomalous interaction of this aromatic-structure-changed variant with 
the gel filtration matrix. In summary, none of the mutations resulted in 
significant disruption of oligomeric structure of the NM23-H1 molecule. 
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Figure 7. Gel filtration HPLC of wild-type and mutant NM23-H1. Purified 
wild-type or mutant NM23-H1 proteins were loaded on a Shodex gel filtration 
HPLC column (Shodex Protein KW-800) pre-equilibrated in 50 mM Tris (pH 
7.5) and 0.1 M KCl at a flow rate of 0.5 ml/min. Elution times of the molecular 
mass standards (Sigma) cytochrome c (12.4 kDa), carbonic anhydrase (29 
kDa), bovine serum albumin (66 kDa), alcohol dehydrogenase (160 kDa), β-
amylase (200 kDa), and blue dextran (2000 kDa) are indicated with arrows. 
The primary peaks of the NM23-H1 variants eluted from the gel filtration 
column are (A) 18.74 min for wild-type NM23-H1. (B) 18.78 min for E5A-H1. 
(C) 18.76 min for Q17N-H1. (D) 18.90 min for Y52A-H1. (E) 18.79 min for P96S-
H1. 
A.  
 
 
 
 
 
B.  
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C.  
 
 
 
 
 
 
D.  
 
 
 
 
 
 
E.  
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Table 3. Molecular weight estimates of NM23-H1 mutants. 
 
Protein Estimated Molecular Weight
1   
WT 87.7 ± 2.1 
E5A 85.1 ± 7.1 
Q17N 86.3 ± 1.5 
Y52A 78.4
*
 ± 3.0  
P96S 84.7 ± 0.4  
 
1 Results were obtained by gel filtration HPLC and are expressed as the mean 
± S.D. in kDa of three replicate determinations (> 2 independent protein 
preparations).  
* Means within a column bearing an asterisk are significantly different (p<0.05).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 38
2.3.6. Circular dichroism analysis indicated NM23-H1 mutants exhibited 
normal secondary structure  
 
        To measure the extent to which the mutations affected secondary 
structure of the NM23-H1 molecule, purified proteins were analyzed by 
circular dichroism (CD) spectrometry. The CD spectra obtained for the wild-
type NM23-H1 (Figure 8) were consistent with the previous report (Ma et al., 
2004) using the same procedure. The secondary structure estimates of wild-
type NM23-H1 were 14% of total α-helix, 33% of β-sheet, 20% of turns, and 
33% of random (Table 4). The CD spectra associated with the E5A, Y52A and 
P96S variants were similar to the wild-type, while the Q17N yielded slightly 
lower helix and higher sheet content than that of wild-type (Table 4). Taken 
together, the gel filtration and CD spectral analyses indicated that each of the 
NM23-H1 mutants employed in this study exhibited normal oligomeric and 3-
dimensional structure.   
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Figure 8. Circular dichroism (CD) analysis of recombinant NM23-H1 
variants. 1.2 µM of purified wild-type (WT) and mutant NM23-H1 proteins 
(E5A, Q17N, Y52A and P96S) were analyzed by CD spectra at 5 oC in a 200-µl 
cuvette (0.1-cm optical path), as described previously (Ma et al., 2004). Each 
spectrum was the average of 30 measurements and data were expressed as 
molar ellipticity. 
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Table 4. Secondary structure estimates of NM23-H1 mutants. 
 
 
 
 
 
1 Secondary structure content is expressed as a percent of the total structure 
and it represents the mean ± S.D. of estimates provided by the three different 
structure prediction programs Contin, Selcon3 and CDSSTR from the online 
DICHROWEB server (lamar.colostate/edu~sreeram/CDPro/).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CD spectrometry1 Protein α Helix β Sheet Turns Random 
WT 14.2 ± 2.8 32.6 ± 5.3 20.0 ± 0.1 32.6 ± 3.8 
E5A 10.7 ± 2.2 35.0 ± 2.5 19.4 ± 0.6 32.9 ± 1.8 
Q17N 8.8 ± 2.6 40.2 ± 4.3 18.7 ± 2.0 32.3 ± 0.7 
Y52A 11.4 ± 4.1 35.9 ± 1.9 19.4 ± 1.4 30.7 ± 1.1 
P96S 13.7 ± 1.7 33.0 ± 1.2 19.8 ± 1.3 32.7 ± 2.0 
 41
2.4. Discussion 
 
        To assess the relevant roles for each of these biochemical activities of 
NM23-H1 in metastasis suppression, we created a panel of NM23-H1 variants 
with selective enzymatic lesions. Previous reports showed that a His118? Phe 
(H118F) substitution totally disrupted NDPK activity but did not affect 3’-5’ 
exonuclease activity, while a K12Q mutation disrupted both NDPK and 3’-5’ 
exonuclease activities (Ma et al., 2004). In the current study, we show that the 
histidine kinase (hisK) activity is also inactivated in each of the 
aforementioned mutants (H118F-0% of WT; K12Q-9% of WT; Table 2). 
Therefore, the K12Q mutant harbors profound lesions in all three enzymatic 
activities (98% reduction in NDPK, 91% loss of hisK, and 82% loss of 3’-5’ 
exonuclease), indicating that Lys12 is required for all enzymatic activities 
associated with NM23-H1. More importantly, E5A substitution results in a 
dramatic and selective disruption in 3’-5’ exonuclease capacity (12% of WT) 
without significant effect on either NDPK or hisK activity, suggesting that the 
active site for the kinase and exonuclease activities could be separated. 
Moreover, loss of the DNA cleavage activity in the E5A and K12Q mutants 
further confirms that the 3’-5’ exonuclease activity of NM23-H1 is not due to 
contamination by bacterial nucleases but is an intrinsic activity of the proteins. 
       Interestingly, although both of Lys12 and Glu5 are necessary for DNA 
cleavage activity of NM23-H1, their mechanisms of action are not the same. 
In contrast to lysine acting as a critical nucleophile through the ε-amino group, 
glutamic acid functions as a nuclease by binding the γ-carboxyl group with 
divalent cation (Shen et al., 1996). Both of these amino acids are highly 
conserved in human NM23 homologues from H1 to H5. 
        Analysis of these mutant proteins by circular dichroism spectrometry 
revealed that none of the amino acid substitutions resulted in significant 
alterations in the secondary structure of NM23-H1. Therefore, losses in 
enzymatic activity observed in this study are likely to reflect specific roles for 
the respective amino acid residues in enzyme activity. 
        The enzymatic activities of NM23-H1 demonstrated in vitro could have 
potential implications for such in vivo processes as DNA replication and repair. 
Conversely, loss of these functions would be expected to lead to accelerated 
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mutation rates, thereby promoting the malignant progression. To test our 
hypothesis that the 3’-5’ exonuclease activity of NM23-H1 may underlie the 
biochemical mechanism of metastasis suppressor by its potential DNA repair 
function, the panel of H1 mutants was generated. The enzymatic deficient H1 
mutants would permit identifications of the relevant enzymatic activity of 
NM23-H1. For example, in metastatic tumor cells with NM23-H1 
overexpression, wild-type-H1 should inhibit the metastatic characterizations of 
the malignant cell while mutant H1 is likely to lose the suppressing effect. The 
defect of the anti-metastatic function would be correlated to the inactivated 
enzymatic activity of mutant H1. The K12Q mutant, harboring lesions in all 
three enzymatic activities, makes it difficult to determine the relevant 
biochemical mechanisms. However, the identification of the E5A mutant in this 
study is promising, because it is the only mutant selectively deficient in 
exonulease activity. Thus, the E5A mutant would provide the possibility to 
discover the relationship between the 3’-5’ exonuclease activity and the 
metastasis-suppressing function of NM23-H1. 
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CHAPTER THREE 
3’-5’ EXONUCLEASE ACTIVITY OF NM23-H1 PLAYS A CRITICAL ROLE 
IN SUPPRESSING IN VIVO SPONTANEOUS METASTASIS  
 
 
3.1. Introduction 
 
        NM23-H1 proteins have been shown to possess multiple enzymatic      
activities, in which nucleoside diphosphate kinase (NDPK), histidine protein 
kinase (hisK) and 3’-5' exonuclease (3’-5’ EXO) activities have been 
extensively investigated. Of these enzymatic activities, 3’-5' exonuclease 
activity of NM23-H1 was identified by our laboratory recently (Ma et al., 2004; 
Ma et al., 2002). However, the relevant biochemical mechanisms underlying 
metastasis suppressor function of NM23-H1 are not very clear yet. The 3’-5’ 
exonuclease activity is a plausible candidate due to the association of the 
enzyme with DNA repair processes and the mutator phenotype often arises 
as a consequence of its deficiency (Shevelev and Hubscher, 2002). Moreover, 
accumulation of mutations is suggested to be required for metastatic 
progression which permits tumor cells to overcome barriers to achieve 
metastases (Loeb, 1991, 2001). Thus we hypothesize that 3’-5’ exonuclease 
activity of NM23-H1 plays an important role in maintaining genomic stability 
and in turn suppressing metastatic progression of tumor cells. To test this 
hypothesis, we have generated a panel of NM23-H1 mutants, including H118F 
(NDPK−, hisK−, EXO+), P96S (NDPK+, hisK−, EXO+), K12Q (NDPK−, hisK−, 
EXO−) and E5A (NDPK+, hisK+, EXO−). The metastasis-suppressing activities 
of these variant NM23-H1 mutants will be analyzed by in vitro and in vivo 
metastasis assays. Loss of anti-metastatic function will be related to the 
inactivated biochemical activity of NM23-H1 mutants. The 3’-5’ exonuclease 
activity was selectively disrupted in the E5A mutant, providing an insight into 
the role of this enzymatic activity in metastasis suppression. Furthermore, this 
panel of NM23-H1 mutants also includes the NDPK and histidine kinase 
deficient mutants (H118F and P96S respectively), the contribution of NDPK and 
histidine kinase activities to the metastasis suppressor function can be 
analyzed by the metastasis assays as well.  
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        Metastasis can be quantified by in vivo assays. There are two types of 
xenograft metastasis assays, spontaneous and experimental (Welch, 1997). 
In a spontaneous metastasis assay, tumor cells are injected into tissue sites 
(i.e. subcutaneously, intradermally, intramuscularly, or into specific organs or 
tissues) which results in formation of a local tumor that will eventually give rise 
to spontaneous metastases. This assay measures the complete metastatic 
process but requires long post-injection time for completion. In an 
experimental metastasis assay, tumor cells are injected into the bloodstream 
of rodents and metastases form quickly and in greater numbers, but this 
assay circumvents the early steps of metastasis, such as local tumor growth 
and intravasation. Full characterization of any metastasis model system 
should include both assays. In our experimental design, a highly metastatic 
melanoma cell line 1205Lu was selected to measure the anti-metastatic 
characteristics of NM23-H1 by both in vivo metastasis assays. The melanoma 
cell line 1205Lu was established from lung metastatic lesions in mice after 
subcutaneous injection of WM793 cells, while the WM793 cell line from the 
vertical growth phase of melanoma represents premetastatic cells. The stably 
transfected 1205Lu cells with wild-type and mutant NM23-H1 variants were 
subcutaneously injected in spontaneous assay and intravenously injected in 
experimental assay. In both models, mice developed lung nodules, therefore 
recapitulating all the steps from primary solid tumor formation to metastatic 
spread. 
 
3.2. Materials and Methods 
3.2.1. Plasmids construction 
        cDNAs encoding the NM23-H1 mutants K12Q, P96S and H118F were 
generated by the overlap extension modification of the polymerase chain 
reaction (PCR), as described (Ho et al., 1989). They were inserted in frame 
between the XhoI and EcoRI sites of the pCI-neo mammalian expression 
vector (Promega). The E5A mutant was constructed using the QuikChange 
site-directed mutagenesis kit (Stratagene). The pCI vector carries the 
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cytomegalovirus (CMV) promoter for high level of DNA expression and the 
neomycin phosphotransferase gene for the selection of stable transfected 
clones. Additionally, in this vector the GFP is co-expressed with NM23-H1 in 
an IRES (Internal Ribosome Entry Segment) expression cassette. The cloned 
PCR products were sequenced by ACGT and Elim Biopharmaceutical Inc. to 
ensure that only desired mutations were present.  
3.2.2. Animals 
        Female athymic nude mice (Harlan, nu/nu; 6-8 weeks old) were obtained. 
Care of mice, surgery and injection protocols were approved by the IACUC at 
the University of Kentucky Medical Center (protocol # 00319M2001 and 
00801M2004). The mice were determined to be free from pathogens and 
caged in groups of four in facilities meeting National Institutes of Health 
guidelines. The mice were euthanatized by intraperitoneal injection of sodium 
pentobarbital (Nembutal, Sigma) at dose of 60 mg/kg. 
3.2.3. Cell culture, stable transfection and flow cytometry 
 
        1205Lu melanoma cells were cultured in MCDB153/L15 medium (Sigma; 
v/v: 4/1) supplemented with CaCl2 (2 mM), insulin (5 mg/ml) and 2% fetal 
bovine serum (FBS) (Gibco). 1205Lu melanoma cells were stable transfected 
with plasmid DNA of wild-type and mutant nm23-H1 (Fugene 6, Roche) and 
selected by geneticin (G418, Life technologies; 250 µg/ml). Cells were sorted 
by fluorescence-activated cell sorting (FACS) using a FACS Calibur Flow 
Cytometer. The sorting procedure yielded more than 95% GFP fluorescent 
cells.  
3.2.4. Spontaneous lung metastasis assay 
        The parent or variant H1-expressing 1205Lu cells were harvested by a 
brief exposure to PBS. Cell numbers and viability were examined using trypan 
blue. Single-cell suspensions of >90% viability were resuspended at 1 x 106 
cells in 100 µl of Hank’s balanced salt solution (Gibco). 2 x 106 1205Lu cells 
of each group were injected subcutaneously into the flank of athymic nude 
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mice. The growth of the tumors was monitored and measured at 3-day 
intervals using vernier caliper. Tumor volumes were calculated by the 
following formula: volume=0.52 x A x B2, where A is the larger and B is the 
smaller axis (Tomayko and Reynolds, 1989). Mice were anesthetized under 
isoflurane and the primary tumors were removed when the tumor size 
reached 0.8-1 cm3. The removed primary tumors were checked for 
fluorescence using Kodak Image Station 4000. The mice were raised for 
another 3 months to permit metastatic growth. At the end of the experimental 
period, mice were euthanatized and lung metastases were scored by counting 
metastatic nodules. The whole procedure of spontaneous metastasis assay is 
illustrated in Figure 9A.  
3.2.5. Experimental lung metastasis assay 
        The metastatic potency of 1205Lu parent cells and variant NM23-H1 
transfectants were also determined using an “experimental metastasis assay” 
(Kath et al., 1991). 2 x 106 parent cells or variant mutant H1-expressing 
1205Lu cells (in a volume of 0.1 ml Hank’s buffer) were injected into the 
lateral tail veins of nude mice. Animals were sacrificed after 1 month and the 
lungs were fixed in Bouin’s solution and scored for metastatic nodules. As 
shown in Figure 9B, the procedure of experimental metastasis assay is 
exhibited. 
3.2.6. Statistical analysis  
        The proportion of metastasis was compared among the seven groups by 
constructing a chi-square statistic for a 7 by 2 contingency table. If significant, 
group response rates will then be compared one to the other by chi-square 
statistics or Fisher’s exact test for a series of 2x2 contingency tables.  
Statistical significance was determined if P < 0.05. 
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Figure 9. Illustration of procedures of in vivo metastasis assays.  
(A) In spontaneous metastasis assay, 2x106 1205Lu parent or nm23-H1 
variant transfected cells were injected subcutaneously into the flank of nude 
mice. When the tumor size reached 0.8-1 cm3, the primary tumors were 
removed and mice were continually raised for three months to permit 
formation of lung metastases. At the end of the experiment, mice were 
sacrificed and lung nodules were counted. (B) In experimental metastasis 
assay, 2x106 1205Lu parent or transfected cells were injected directly into tail 
vein of nude mice. One month later, mice were sacrificed and metastatic lung 
nodules were scored. 
A.  
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B.     
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3.3. Results 
3.3.1. NM23-H1 expression does not affect primary tumor growth of 
1205Lu melanoma cells.  
 
        Parent and stably transfected 1205Lu cells with NM23-H1 variants were 
injected subcutaneously into athymic nude mice and the growth of primary 
tumors were monitored over time. The sizes of primary tumors were 
measured by calipers and after four weeks, tumor volumes reached 0.8-1.0 
cm3. As shown in Figure 10, the primary tumor formed by wild-type NM23-H1 
transfected 1205Lu cells was not significantly different from that of parent 
cells, suggesting expression of wild-type-H1 had no inhibitory effect on 
primary tumor growth of 1205Lu cells in vivo. Once the size of primary tumor 
reached 0.8-1.0 cm3, tumors were removed and mice were continually raised 
for another 3 months to form lung metastases.  
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Figure 10. NM23-H1 expression does not affect primary tumor growth. 
2x106 parent and variant NM23-H1-expressing 1205Lu cells were 
subcutaneously injected on the flanks of mice to form primary tumors. The 
size of primary tumors was measured by calipers every 3-4 days. Primary 
tumor growth from wild-type NM23-H1, H118F-H1 and P96S-H1 transfected 
cells had no significant difference compared to that of 1205Lu parent cells. 
The tumor formed in K12Q-H1- and E5A-H1-transfected cells exhibited slower 
growth than parent cells after day 20, however, they still reached the target 
size of 0.8-1.0 cm3 on day 30 (5 days later than other groups). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
         
 51
3.3.2. The E5A and K12Q mutations disrupt metastasis suppressor 
activity of NM23-H1.  
 
        Three months after the primary tumors being removed, all mice were 
sacrificed and lungs were examined for metastatic nodules. Lung metastases 
were scored as plus or minus and metastasis rate was calculated by number 
of mice with lung metastasis over total number of mice in this group. As 
shown in Table 5, a 64% metastasis rate was observed in the parent 1205Lu 
cells, a relatively high penetrance for this cell line. Expression of the wild-type 
NM23-H1 significantly suppressed the spontaneous metastasis rate to 24%, 
consistent with its previously described metastasis suppressor activity (Table 
5). Unexpectedly, the P96S mutant exhibited full metastasis suppressor activity 
(Table 5), in contrast with previous reports (Hartsough et al., 2002). However, 
the E5A and K12Q mutations resulted in a nearly complete loss of suppressor 
activity (Table 5). The H118F mutant also exhibited less metastasis-
suppressing activity than the wild-type, but the reduction failed to achieve 
statistical significance. As shown in Figure 11, the spontaneous lung 
metastases from 1205Lu parent cells and E5A-H1 group were much more 
severe than that of the wild-type group. 
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Table 5. The K12Q and E5A mutations result in complete loss of 
metastasis suppressor activity for NM23-H1. After primary tumors were 
excised, mice were raised for another 3 months to permit lung metastases. At 
the end of the experiment, all mice were sacrificed at the same day and lungs 
were examined for metastatic nodules. Metastasis rate in each group is 
presented as a percent of number of mice with lung metastasis/total mice 
number in this group.  
 
1205Lu cell lines # of mice with lung metastasis/ # of total mice1 Percentage rate 
Parent 14/22 64a,b 
WT-H1 9/37 24c 
E5A 13/26 50
a,b 
K12Q 14/24 58
a,b 
P96S 6/24 25
c 
H118F 8/20    40
a,b,c 
 
1Qingbei Zhang and Marian Novak contributed to the data shown above. 
a,b,c Values not sharing a common superscript are significantly different (p < 
0.05). 
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Figure 11. Representative pictures of spontaneous lung metastases 
from 1205Lu parent cell group (a and b), wild-type-H1 group (c and d) 
and E5A-H1 group (e and f).  
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3.4. Discussion 
 
        The molecular mechanism(s) underlying the metastasis suppressor 
activity of NM23 proteins still remain controversial. Currently, the most widely 
accepted model involves the histidine kinase (hisK) activity of NM23-H1 as 
some evidence suggests that this enzymatic activity is necessary for inhibition 
of cell motility and suppression of Map kinase activation via phosphorylation 
of the kinase suppressor of Ras (KSR) in MDA-MB-435 breast carcinoma 
cells (MacDonald et al., 1996). However, direct evidence for the relevance of 
hisK to in vivo metastasis suppression has not been determined. In this study, 
we propose that the 3’-5’ exonuclease activity of NM23-H1 plays an important 
role in suppressing metastasis by maintaining genomic integrity. However, an 
efficacious metastasis suppressor might be expected to exert multiple 
activities at multiple levels. Therefore, our hypothesis does not exclude the 
possibilities that other known enzymatic activities of NM23-H1 could also 
contribute to the anti-metastatic function. To this end, a panel of variant 
NM23-H1 mutants has been developed and used to systematically determine 
the relevant contributions made by each of the primary enzymatic activities of 
NM23-H1. 
        To assess the anti-metastatic function of NM23-H1, the human 
metastatic melanoma cell line 1205Lu was chosen as an experimental model 
in this project for a number of reasons. First, melanoma represents the 
prototypical setting for the metastasis suppressor NM23-H1, since the 
metastasis suppressor activity of NM23 was originally identified in the murine 
melanoma cell line K-1735 (Steeg et al., 1988). Second, 1205Lu cells 
exhibited highly metastatic characteristics in a number of in vitro and in vivo 
models. Third, orthotopic tumor inoculation (subcutaneous injection) of 
melanoma cells is easy to be performed on animals. Finally, and most 
importantly, my colleague has demonstrated that 1205Lu cells expressed very 
low amounts of NM23-H1 and NM23-H2 (Qingbei Zhang, Ph.D. dissertation, 
2006), consistent with a classical model of reduced NM23 expression in 
melanoma metastases. This low level of NM23 expression also provides a low 
background upon which the anti-metastatic activity of wild-type and mutant 
NM23-H1 can be determined.  
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        NM23-H1-expressing plasmids and pSV2neo were co-transfected into 
1205Lu cell line. Stably transfected cells were selected by neomycin analogue 
G418 and enriched by sorting of GFP-fluorescent cells. Same intensity of 
GFP fluorescence in variant H1-transfected cells indicated that equal amount 
of NM23-H1 was expressed. To measure the anti-metastatic ability of wild-
type and mutant NM23-H1, parent and variant NM23-H1-expressing 1205Lu 
cells were injected into athymic nude mice by standard approaches of 
spontaneous and experimental metastasis assays.  
        In the spontaneous metastasis model, forced expression of wild-type 
NM23-H1 had no effect on primary tumor growth of 1205Lu cells, but  in K12Q-
H1 and E5A-H1 overexpressed cells the primary tumor growths were slower 
than that of parent cells. However, subsequent replication of these studies by 
my colleague (Marián Novak) has demonstrated that there is, in fact, no 
statistical difference in primary tumor growth rates. Therefore, NM23-H1 still 
fits the definition of metastasis suppressor, by which it does not affect primary 
tumor growth when inhibiting tumor metastasis.  
        At the end of this experiment, wild-type NM23-H1 and P96S mutant 
significantly suppressed the spontaneous lung-metastasis rate of 1205Lu cells  
to 24% and 25% respectively, while the K12Q and E5A mutants lost the 
metastasis-suppressing effects exhibited by the wild-type-H1 (Table 5). Based 
on these observations, the actions of these mutants on lung metastases need 
to be discussed one by one. -1- Since E5A-H1 is an exonuclease-deficient 
mutant with full NDPK and hisK activities, loss of metastasis suppressor 
activity of this mutant would directly suggest that the 3’-5’ exonuclease activity 
of NM23-H1 is required to suppress lung metastasis from melanoma lesion. -
2- The histidine kinase activity of NM23-H1 seems not to contribute to the 
metastasis suppressor function, since the hisK-deficient P96S mutant still 
maintains the full anti-metastatic capacity. -3- The H118F mutant is deficient in 
both NDPK and hisK activities. Since the apparent loss of anti-metastatic 
activity with the H118F mutant was not statistically significant, relevance of the 
NDP kinase to anti-metastasis function could not be demonstrated. -4- The 
K12Q mutant lacks all three of these enzymatic activities and also disrupts the 
metastasis-inhibiting capacity. As discussed above, if either NDPK or hisK 
activity is not involved in the mechanism of metastasis suppression, 3’-5’ 
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exonuclease must be necessary to suppress metastasis in 1205Lu melanoma 
cells, consistent with the result of the E5A group. Taken together, all these 
results strongly indicate that 3’-5’ exonuclease activity of NM23-H1 plays 
important roles in suppressing spontaneous lung metastasis in 1205Lu 
melanoma cells. In contrast with a previous report that the histidine kinase 
activity might mediate the metastasis suppressor function of NM23-H1 
(Hartsough et al., 2002), in this study, it does not seem to be involved in this 
function. 
        In the experimental metastasis assays (performed by my colleagues 
Qingbei Zhang and Marián Novak) , the tail vein injection of 2x106 1205Lu 
parent cells led to an 87% of metastasis. However, unlike what we expected, 
overexpression of wild-type NM23-H1 didn’t significantly inhibit the lung 
metastasis. These observations suggested that NM23-H1 lost the metastasis 
suppressor function when a large number of melanoma cells directly entered 
the blood system. These cells flowed to the lungs and were trapped within 
pulmonary capillaries, followed by intravascular proliferation and eventual 
colonization in the lung. In this process, early steps of the metastatic 
progression were omitted, including the loss of cellular adhesion, increased 
motility and invasion, entry and survival in the circulation. Therefore, the 
experimental metastasis accelerated the metastatic period and increased the 
metastatic efficiency. The observations that NM23-H1 was able to inhibit the 
metastasis in the spontaneous metastasis model but not in the experimental 
metastasis model suggested that NM23-H1 may mediate the suppressing 
effects on the earlier steps of metastasis. This idea is supported by our in vitro 
studies of 1205Lu cells, which showing that overexpression of wild-type 
NM23-H1 inhibited motility and invasion of the cells (Qingbei Zhang, Ph.D. 
dissertation, 2006). Another evidence is that forced expression of NM23-H1 
inhibited anchorage independent growth in soft agar in MDA-MB-435 and 
MDA-MB-231 cells (McDermott et al., 2007). Furthermore, overexpression of 
NM23-H1 in human breast carcinoma cells led to the formation of basement 
membrane and growth arrest (Howlett et al., 1994), which also supported the 
idea that NM23-H1 performs a suppressor function in the early stages of 
metastasis.    
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        Interestingly, the effects of NM23-H1 mutants on the in vivo spontaneous 
metastasis assay of 1205Lu cells were consistent with an in vitro assay 
developed in the Kaetzel laboratory using the non-metastatic melanoma cell 
line WM793 (performed by Qingbei Zhang and Marián Novak). The WM793 
cell line was derived from a vertical growth phase (VGP) melanoma, a highly 
invasive but non-metastatic form of the disease. Expression of NM23 was 
undetectable in this cell line. This non-metastatic cell line can progress to a 
metastatic phenotype under strong selective pressure, such as culturing in 
protein-free (growth factor-free) medium (Kath et al., 1991). The unpublished 
data achieved by my colleagues demonstrated that forced expression of wild-
type NM23-H1 significantly blocked the progression process of WM793 cells 
in protein-free medium. Moreover, similar to the pattern observed in 1205Lu 
cells, K12Q but not P96S mutant lost the effects of anti-progression exhibited 
by wild-type-H1. This observation further demonstrated that 3’-5’ exonuclease 
activity of NM23-H1 is likely to mediate the biochemical mechanisms in 
metastasis suppression. 
        Evidence from in vivo spontaneous metastasis assay of 1205Lu cells 
and in vitro progression assay of WM793 cells strongly indicates that the 3’-5’ 
exonuclease activity of NM23-H1 is important to suppress metastasis and 
metastatic progression of melanoma cells. The underlying mechanisms could 
be that 3’-5’ exonuclease activity participates in DNA repair or other aspects 
of cellular function to maintain genomic integrity. The properties of NM23-H1 
in maintenance of genomic stability will be addressed in next chapter.       
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CHAPTER FOUR 
ANALYSIS OF DNA REPAIR ACTIVITY FOR YNK1, THE YEAST 
SACCHAROMYCES CEREVISIAE HOMOLOGUE OF METASTASIS 
SUPPRESSOR NM23 
 
 
4.1. Introduction 
 
        Nucleoside diphosphate kinase (NDPK) catalyzes the transfer of a γ-
phosphate between nucleoside triphosphate and nucleoside diphosphate via 
a “ping-pong” mechanism (Agarwal et al., 1978). NM23 is a highly conserved 
enzyme from prokaryotes to eukaryotes, with their three-dimensional 
structures showing remarkable similarity (Dumas et al., 1992), indicating that 
NDP kinase evolution is highly conservative. In addition to NDPK activity, 
NDP kinase has been determined to have a number of other important cellular 
and biochemical functions in different species. 
        NM23-H1 was first identified by virtue of its reduced expression in highly 
metastatic melanoma and breast carcinoma cells, and the ability of forced 
NM23-H1 expression to inhibit metastatic potential without significant impact 
on the transformed phenotype (Steeg et al., 1988). In addition to NDPK 
activity, NM23-H1 also exhibits both protein histidine kinase (HisK) (Freije et 
al., 1997) and 3’-5’exonuclease (3’-5’EXO) activities (Ma et al., 2004). 
Generally, enzymes that contain 3’-5’ exonuclease activity are involved 
directly in DNA repair processes and maintenance of genomic stability 
(Shevelev and Hubscher, 2002). Here, we hypothesize that the loss of the 3’-
5’ exonuclease activity of NM23-H1 during tumor progression impairs 
genomic integrity, thereby enhancing metastatic potential.  
        Previous studies provide compelling evidence on the potential DNA 
repair functions of NM23. Ndk-disrupted strain of Escherichia coli exhibited a 
mutator phenotype with significantly increased frequencies of spontaneous 
mutations resistant to rifampicin and nalidixic acid (Lu et al., 1995). This is a 
direct evidence for the anti-mutator function of the prokaryotic homologue of 
NM23. In yeast mutagenesis studies, expression of YNK1, the budding yeast 
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homologue of NM23, was significantly increased in response to treatment with 
the DNA methylating agent methyl methanesulfonate (MMS) (Gasch et al., 
2001). In addition, our unpublished data show that NM23-H1 accumulates and 
co-localizes with nuclear foci following the treatment with DNA damaging 
agents etoposide, cisplatin and UV radiation. UV radiation seems to have a 
stronger effect on this observation than etoposide and cisplatin. These DNA 
damage responses further suggest a DNA repair function of NM23-H1.  
        In an effort to quantify the contribution of NM23-H1 to DNA repair, we 
have initiated experiments in the yeast Saccharomyces cerevisiae. S. 
cerevisiae provides an excellent eukaryotic model for DNA repair research, 
since knockout strains are available for essentially all genes including those 
involved in DNA repair mechanisms. These characteristics of S. cerevisiae 
provide a genetic model for rapid and convenient analysis of the role of YNK1 
in DNA repair. In this project, we measured the impact of deletion of the YNK1 
on the mutation rate in S. cerevisiae.   
 
 
4.2. Materials and Methods 
 
4.2.1. Yeast strains and media 
 
        The single mutant strains (Open Biosystems) used as parent strains in 
this study were derived from BY4741 or BY4742 wild-type strain and their 
genotypes are listed in Table 6. The ORF for each gene of interest was 
replaced with a KanMX-selectable marker by a PCR-based strategy. The 
double mutant strain was constructed by crossing ynk1:: kanMX mutant with 
an isogenic strain harboring another deletion in one of  DDC1, RAD17, MEC3, 
MSH2, and RAD27 genes. Genotypes were verified for resultant haploid 
derivatives of each mutant strain by PCR analysis using primer pairs specific 
for either the wild-type or mutant allele. Yeast strains were grown in standard 
media including yeast extract/peptone/dextrose (YPD) medium or synthetic 
drop-out medium (SD) lacking the appropriate amino acid. Canavanine-
resistant mutants (Canr) were selected on SD arginine-dropout plates 
containing 60 mg/liter L-canavanine sulfate (Sigma). 
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Table 6. S. cerevisiae strains used in this study 
 
Strain  Genotype 
BY4741   a. his3∆1 leu2∆0 met15∆0 ura3∆0 
BY4742  α. his3∆1 leu2∆0 lys2∆0 ura3∆0 
ynk1  a. his3∆1 leu2∆0 met15∆0 ura3∆0 ynk1::kanMX  
ddc1  α. his3∆1 leu2∆0 lys2∆0 ura3∆0 ddc1::kanMX 
rad17  α. his3∆1 leu2∆0 lys2∆0 ura3∆0 rad17::kanMX 
mec3  α. his3∆1 leu2∆0 lys2∆0 ura3∆0 mec3::kanMX 
msh2  α. his3∆1 leu2∆0 lys2∆0 ura3∆0 msh2::kanMX 
rad27  α. his3∆1 leu2∆0 lys2∆0 ura3∆0 rad27::kanMX 
ynk1 ddc1  his3∆1 leu2∆0 met15∆0 ura3∆0 ynk1::kanMX ddc1::kanMX 
ynk1 rad17  his3∆1 leu2∆0 lys2∆0 ura3∆0 ynk1::kanMX rad17::kanMX 
ynk1 mec3  his3∆1 leu2∆0 ura3∆0 ynk1::kanMX mec3::kanMX 
ynk1 rad27  his3∆1 leu2∆0 lys2∆0 ura3∆0 ynk1::kanMX rad27::kanMX 
ynk1 msh2  his3∆1 leu2∆0 met15∆0 ura3∆0 ynk1::kanMX msh2::kanMX 
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4.2.2. UV sensitivity assay 
 
        Individual colonies were inoculated into 1 ml of YPD medium and grown 
overnight with shaking at 250 rpm at 30oC to a density of 2 x 108 cells/ml. 100 
µl of the appropriate cell dilution were plated in triplicate on YPD agar plates 
to assess cell survival. Within an hour of plating, cells were exposed to UV 
light on a time course. After UV exposure the plates were immediately stored 
in incubator at 30oC. Cell viability was the fraction of plated cells which gave 
visible colonies after 3 to 4 days of growth on YPD plates. Each data point 
corresponds to the mean of 3 independent experiments, and error bars 
represent the standard deviation in Figure 14.  
 
4.2.3. CAN1 forward mutation assay 
 
        Individual colonies were inoculated into 1 ml of YPD medium and grown 
overnight with shaking at 250 rpm at 30oC to a density of 2 x 108 cells/ml. 
Cells were washed once with sterile distilled water and then resuspended in 1 
ml of sterile 50 mM potassium monohydrogen/dihydrogen phosphate buffer, 
pH 7.0. For determination of Canr mutation rates, 100 µl of an appropriate 
dilution (~100 cells) was plated on SD-arginine (SD-arg) medium and 200 µl 
of the remaining culture (~4 x 107 cells) was plated on SD-arginine containing 
canavanine (SD+can) medium. Plates were incubated for 5 days at 30°C, and 
the number of Canr colonies was counted. Mutation rates were determined by 
the method of the median (Lea and Coulson, 1948), and 95% confidence 
intervals (CIs) were calculated as described in this reference. At least 10 
independent cultures were used for all measurements of mutation rate. 
 
4.2.4. MMS-induced mutagenesis 
 
        1 ml of cells was grown overnight in YPD medium, harvested and 
resuspended in 1 ml of 50 mM potassium phosphate, pH 7.0. Methyl 
methanesulfonate (MMS) was added to 0.1% and cells were incubated at 
30°C with shaking for 40 min. An equal volume of 10% ice cold sodium 
thiosulfate was added to the culture and incubated for 10 min. The cells were 
 62
harvested, washed twice with sterile water and then suspended in 50 mM 
potassium phosphate, pH 7.0. Cells were diluted and plated on SD plates 
followed by the standard CAN1 mutation assay.  
 
4.2.5. UV-induced mutagenesis 
 
        1 ml of cells was grown overnight in YPD medium, harvested and 
resuspended in 1 ml of 50 mM potassium phosphate, pH 7.0. Cells were 
diluted and plated on SD-arg and SD+can medium. The SD+can plates were 
then exposed to UV light at a dose of 70% cell viability. All plates were 
incubated for 5 days at 30°C, and the rest procedure followed the standard 
CAN1 mutation assay. 
 
4.2.6. Fluctuation analysis 
 
        To determine CAN1 mutation frequency, at least 10 independent cultures 
were analyzed in each experiment and each experiment was repeated for at 
least two times. The method of the median (Lea and Coulson, 1948) was 
used to calculate CAN1 mutation rate and 95% confidence interval of each 
rate. 
 
4.2.7. Sequence analysis of CAN1 mutation spectra 
 
        Independent Canr colonies were isolated, and genomic DNA was 
extracted with yeast DNA extraction kit (Pierce). CAN1 gene was amplified by 
PCR and sequenced at UK Advanced Genetic Technologies Center. 
Sequencing analysis was done using NCBI Blast request.  
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4.3. Results 
 
4.3.1. ynk1∆ strain displays a UV-induced mutator phenotype. 
 
        ynk1∆ strain didn’t display defects in growth rate, spore formation, 
mating ability or morphology (Fukuchi et al., 1993). In our studies, ynk1∆ 
mutants exhibited no increase in spontaneous mutation rate than wild-type 
strain from the described CAN1 forward mutation assay. Then both wild-type 
and ynk1∆ strains were treated with DNA damaging agents MMS and UV 
radiation. 0.1% MMS induced an 11-fold increase in mutation rate at CAN1 
locus in ynk1∆ strain, compared to an 8-fold mutation increase in wild-type 
strain (Figure 12A). However, the ratio of UV-induced mutation rate to 
spontaneous mutation rate at CAN1 locus in ynk1∆ strain was 13:1, while 
wild-type strain exhibited a 5-fold increase in UV-induced mutation rate. The 
fold increase rate (13:5) between ynk1∆ and wild-type strains was significantly 
different analyzed by one way ANOVA (Figure 12B). In addition, the UV-
induced mutator phenotype was reproducible in ynk1∆ spore cells generated 
from double mutants, in which the fold increase (UV-induced mutation 
rate/spontaneous mutation rate) was consistently 2-3 fold higher than their 
wild-type sporemates (data not shown). These results suggested that YNK1 
deletion led to a moderate, but significant repair deficiency to UV-induced 
DNA damage.  
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Figure 12. Deletion of YNK1 results in increased mutations in response 
to MMS and UV insults. The CAN1 forward mutation rate was measured in 
both wild-type and ynk1∆ strains under either spontaneous conditions or 
following the treatment with DNA damaging agents MMS or UV.  (A) 0.1% 
MMS was used to induce CAN1 mutation rate. (B) A dose of 192 J/m2 of UV 
radiation was used to induce CAN1 mutation rate. Both treatments resulted in 
a 70% viability rate for both strains. 10 independent cultures were used for all 
measurements and at least three experiments were performed, data was 
analyzed by one way ANOVA. 
A.  
 
 
 
 
 
 
B. 
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4.3.2. CAN1 mutation spectra analysis  
 
        CAN1 encodes an arginine permease (Ahmad and Bussey, 1986), and 
any loss-of-function mutation at this locus confers resistance to canavanine. 
To better understand the accumulation of mutations in the ynk1∆ strain, the 
mutation spectra for both of wild-type and ynk1∆ strains was determined by 
sequencing the CAN1 gene from approximately 20 independent Canr isolates. 
As shown in Table 7, under basal conditions, the Canr mutations in wild-type 
cells were base substitutions (59%) and deletions (23%), while ynk1∆ cells 
had 70% of base substitutions and 6% of deletions. In UV-irradiated wild-type 
cells the frequency of base substitutions was 53% and deletion 21%, which 
resembled that of no treatment. The UV-irradiated ynk1∆ cells demonstrated 
70% of base substitutions and 15% of frameshifts. Notably, the frameshift 
events were only shown in this group. In addition, it’s interesting to note that a 
frequency of thymidine (T) tract (at least three T in order) mutation alterations 
in this group was as high as 65%, which was remarkably higher than any 
other groups (e.g., 18% in wild-type cells with no treatment, 24% in ynk1∆ 
cells with no treatment and 26% in UV-irradiated wild-type cells).  
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Table 7. CAN1 forward mutation spectrum 
 
                             Canr Genotype Event 
Mutation Frequency 
G→T 2/17 
G→A 4/17 
T→G 1/17 
C→A 1/17 
C→T 1/17 
T→C 1/17 
Base substitution  
Total 10/17(59%) 
Frameshift  0/17(0%) 
29 bp 2/17 
~100 bp 1/17 
~200 bp 1/17 
Deletion 
Total 4/17(23%) 
Complex ACACCACAG→ 
CACAA 
1/17(6%) 
Wild type 
No mutation   2/17(12%) 
G→A 3/17 
T→A 1/17 
A→T 1/17 
C→A 2/17 
C→T 3/17 
C→G 2/17 
Base substitution 
Total 12/17(70%) 
Frameshift  0/17(0%) 
Deletion ~200 bp 1/17(6%) 
Complex  0/17(0%) 
ynk1∆ 
No mutation   4/17(24%) 
G→A 2/19 
G→T 3/19 
T→C 3/19 
C→A 1/19 
C→G 1/19 
Base substitution 
Total 10/19(53%) 
Frameshift  0/19(0%) 
CGAA→C∆AA 1/19 
TTTAT→TTT∆T 1/19 
~150 bp 1/19 
~350 bp 1/19 
Deletion 
Total 4/19(21%) 
AAATTA→TAATTT 1/19 
CATTGCGCTC→ 
TATGCGCTT 
1/19 
Complex 
Total 2/19(10%) 
Wild type  
with UV 
treatment 
No mutation   3/19(16%) 
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G→A 4/20 
G→T 2/20 
T→A 3/20 
C→T 3/20 
A→G 1/20 
C→A 1/20 
Base substitution 
Total 14/20(70%) 
T4→T2 1/20 
T5→T6 1/20 
T6→T7 1/20 
Frameshift 
Total 3/20(15%) 
Deletion TTTTCTT→ 
TTTT∆TT 
1/20(5%) 
Complex (TATTT)2→(T)11 1/20(5%) 
ynk1∆ 
with UV 
treatment 
No mutation   1/20(5%) 
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4.3.3. The double deletion between YNK1 and 9-1-1 component causes a 
decrease in UV-induced mutagenesis. 
 
        Since redundancy of DNA repair mechanisms exist in cells, loss of one 
gene function can be compensated by a separate pathway. At this point, to 
study the possible interactions of YNK1 with other DNA repair mediators, 
double knockout mutants were generated in ynk1∆ background, which 
harbored a second deletion in a variety of known DNA checkpoints or DNA 
repair genes (DDC1, RAD17, MEC3, RAD27 and MSH2). Ddc1p, Rad17p, 
and Mec3p proteins form a heterotrimeric ring, with similar structure to 
proliferating cell nuclear antigen (PCNA) in S. cerevisiae (Majka and Burgers, 
2003; Thelen et al., 1999). Their human homologues are RAD9, RAD1, and 
HUS1 respectively (9-1-1 complex). The 9-1-1 complex is a DNA damage 
checkpoint and causes cell cycle arrest in response to DNA damage (Kondo 
et al., 1999). Our microarray analysis has identified an elevated HUS1 
expression in association with the loss of NM23 in metastatic cell lines.  
        The double mutant strain was generated by crossing a ynk1∆ mutant 
with another knockout mutant (e.g. rad17∆) and four isogenic spores (e.g. 
wild-type, ynk1∆, rad17∆ and ynk1∆ rad17∆) were isolated from a double 
knockout diploid cell. The mutator phenotypes of the generated mutant cells 
were analyzed by CAN1 forward mutation assay and compared with their 
wild-type counterparts. Under spontaneous conditions, CAN1 mutation rates 
of rad17∆, mec3∆ and ddc1∆ mutants exhibited 2.5-fold, 2.3-fold and 2.4-fold 
respectively higher than the wild-type cell (Table 8), consistent with previous 
study (Paulovich et al., 1998). As expected, the ynk1∆ rad17∆, ynk1∆ mec3∆ 
and ynk1∆ ddc1∆ double mutants displayed similar mutation rates as the 
rad17∆, mec3∆ and ddc1∆ single mutants, since the deletion of YNK1 didn’t 
affect the spontaneous mutation rate compared to wild-type cell (Table 8). 
Meanwhile, the 9-1-1 single mutants and double mutants were treated with 
UV radiation at different low doses according to their 70% UV viable rate. 
Compare to UV-irradiated wild-type cells, UV-induced mutation rate of 9-1-1 
single mutants was reduced by about 50%. The UV-induced mutation rate of 
ynk1∆ ddc1∆, ynk1∆ rad17∆ and ynk1∆ mec3∆ double mutants was close to 
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the ddc1∆, rad17∆ and mec3∆ single mutant, but 70-80% lower than the 
ynk1∆ cell (Table 8). 
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Table 8. Forward mutation rates at the CAN1 locus in wild-type and 
mutant strains. 
 
Mutation rates shown here are the averages of at least two independent 
experimental sets. Fold increases in mutation rates compared to wild type are 
indicated in parentheses.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Canr mutation rate per 107 cells (fold increase) 
Strain 
spontaneous UV-induced 
Wild type 1.6 (1) 8 (1) 
ynk1∆ 1.6 (1) 20 (2.5) 
ddc1∆ 3.9 (2.4) 3.2 (0.4) 
ynk1∆ ddc1∆ 4.0 (2.5) 5.5 (0.7) 
rad17∆ 4.0 (2.5) 4.4 (0.6) 
ynk1∆ rad17∆ 4.0 (2.5) 3.5 (0.4) 
mec3∆ 3.6 (2.3) 4.8 (0.6) 
ynk1∆ mec3∆ 5.2 (3.3) 5.7 (0.7) 
rad27∆ 89 (56) 46 (5.8) 
ynk1∆ rad27∆ 60 (38) 32 (4) 
msh2∆ 28 (18) 24 (3) 
ynk1∆ msh2∆ 34 (21) 34 (4.3) 
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4.3.4. Deletion of YNK1 does not affect UV sensitivity of the ddc1∆, 
rad17∆ or mec3∆ mutant.  
 
        UV sensitivity of the ynk1∆ ddc1∆, ynk1∆ rad17∆ and ynk1∆ mec3∆ 
double mutants was measured at gradient UV doses. As shown in Figure 13, 
ynk1∆ mutants did not exhibit more sensitivity than wild-type strain. The 
ddc1∆, rad17∆ or mec3∆ single mutants were very sensitive to the killing 
effects of UV radiation, as previously reported (Longhese et al., 1997; 
Paulovich et al., 1998). However, the deletion of YNK1 did not affect the UV 
sensitivity of ddc1∆, rad17∆ and mec3∆ mutant in our studies. 
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Figure 13. Deletion of YNK1 does not affect UV sensitivity of the wild-
type cell and the 9-1-1 mutant. Cell viability was measured in wild-type, 
ynk1∆, ddc1∆, rad17∆, mec3∆ and the corresponding double mutants, 
following UV exposure at a gradient dose.   
A.  
 
 
 
 
 
B.  
 
 
 
 
 
C.  
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4.3.5. Characterization of the Canr mutations of the ynk1∆ rad27∆ and 
ynk1∆ msh2∆ double mutants  
 
        S. cerevisiae RAD27 (homologue of human FEN1) proteins exhibited a 
5’-3’ exonuclease activity and an endonuclease activity involved in DNA 
replication and repair (Harrington and Lieber, 1994; Qiu et al., 2001). rad27 
mutants displayed a strong spontaneous mutator phenotype and showed 
increased rates of chromosome instability (Tishkoff et al., 1997). To examine 
the relationship between YNK1 and RAD27, a ynk1 rad27 double knockout 
mutant was constructed by crossing a ynk1∆ mutant to an isogenic rad27∆ 
mutant and dissecting tetrads from the resulting diploid. In comparison to the 
wild-type cell, deletion of RAD27 caused a significantly greater increase in the 
spontaneous Canr mutation rate (56-fold higher), which was consistent with 
previous studies (Tishkoff et al., 1997). The mutation rate in ynk1∆ rad27∆ 
mutant was 30% lower than rad27∆ mutant. With UV dose of 70% viable rate, 
the rad27∆ mutants had a 5.8-fold higher Canr mutation rate than the wild-
type strain, while the ynk1∆ rad27∆ double mutants displayed a Canr mutation 
rate (3.2 × 10-6) situated between ynk1∆ (2.0 × 10-6) and rad27∆ (4.6 × 10-6)  
single mutants (Table 8).  
        The products of mismatch repair genes MSH2, MSH3 and MSH6 in S. 
cerevisiae (MutS homologue of E. coli) form two complexes, Msh2p-Msh6p 
complex and Msh2p-Msh3p complex (Kolodner, 1996; Marsischky et al., 
1996). They bind and function in the repair of base-base and 
insertion/deletion mispairs, and reduce the accumulation of mutations during 
DNA replication. To study the relationship between YNK1 and MSH2, a ynk1 
msh2 double knockout mutant was constructed. Mutagenesis analysis 
showed that msh2∆ mutants exhibited increased Canr mutations (18-fold 
higher) than wild-type cells, consistent with previous reports (Lau et al., 2002). 
The ynk1∆ msh2∆ double mutants showed a slight increase in spontaneous 
mutation rate compared to msh2∆ single mutants. Following the UV treatment, 
the msh2∆ mutants displayed a similar mutator phenotype as the ynk1∆ 
mutants (3-fold higher than wild-type), while the ynk1∆ msh2∆ double mutants 
showed a small additive effect. The effects of the deletion of YNK1 and MSH2 
on UV-induced mutagenesis seemed to be added (Table 8). 
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4.4. Discussion 
         UV irradiation leads to DNA damage, primarily due to covalent linkage 
between adjacent pyrimidines. Such photoproducts block the progression of 
DNA polymerases and are potentially mutagenic. Nucleotide excision repair 
proteins are recruited to the site of the lesion and repair the damage in an 
error-free manner. This form of DNA repair reduces the mutation frequency 
induced by UV irradiation. If the damage persists when the DNA is replicated 
in S-phase of the cell cycle, translesion synthesis (TLS) is activated using an 
error-prone mechanism that involves the non-processive DNA polymerase 
zeta (Polζ) (McGregor, 1999). Polζ is consists of two subunits, catalytic 
subunit REV3 and regulatory subunit REV7 (Nelson et al., 1996). Polζ is 
required for the induction of mutations and Polζ mutants caused a decrease in 
UV-induced mutagenesis. Recent studies demonstrated that the MEC3 and 
DDC1 subunits of the 9-1-1 complex physically and functionally interacted 
with the REV7 subunit of the Polζ, and the complex was required to stably 
recruit Polζ onto damaged DNA (Sabbioneda et al., 2005). This evidence 
provides an explanation for reduction in UV-induced mutagenesis in yeast 9-
1-1 single mutants.  
        ynk1∆ strains displayed a significant UV-induced mutator phenotype that 
was assessed by measuring resistance to the toxic arginine analog 
canavanine, which suggests that YNK1 is likely to play an important role in 
interacting with the UV damaged DNA. The Canr mutation spectrum indicates 
that the mutations in the ynk1∆ strain primarily resulted from nucleotide mis-
incorporation and frameshift events, which can increase the frequency of DNA 
polymerase slippage, therefore enhancing the mutation rate. We suggest 
three possible explanations for the DNA damage-dependent anti-mutator 
function of YNK1: 1) YNK1 possibly functions as a redundant 3’-5’ 
exonuclease involved in DNA damage repair pathway; 2) YNK1 is likely to be 
a redundant 3’-5’ exonuclease facilitating DNA polymerase fidelity; 3) the 
NDPK activity of YNK1 maintains the intracellular nucleotide balance, as the 
increased dCTP content has been suggested to result in the mutator 
phenotype in ndk deficient E. coli strain (Lu et al., 1995).  
        Nucleotide excision repair (NER) is primarily implicated in repair of UV-
induced DNA damage by an error-free manner. YNK1 could possibly be 
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involved in the NER pathway by functioning as a redundant 3’-5’ exonuclease 
to reduce mutations. The potential relationship of YNK1 and DNA damage 
checkpoints (DDC1, RAD17, MEC3) or DNA repair enzymes (RAD27 and 
MSH2) was probed by mutation rate measurements in a double knockout 
strain. The effect of YNK1 in UV-induced mutagenesis is suppressed in ynk1∆ 
ddc1∆, ynk1∆ rad17∆ and ynk1∆ mec3∆ double mutants, suggesting that 
YNK1 is not likely to be involved in the 9-1-1 clamp regulated pathway. 
Rad27p, a structure-specific endo/exonuclease, plays an important role in 
DNA replication through Okazaki fragment maturation and DNA repair of 5'-
blocked ends (Tishkoff et al., 1997). Based on the decrease in mutation rates 
of ynk1∆ rad27∆ double mutants compared to rad27∆ single mutants, YNK1 
does not seem to coordinately interact with RAD27. However, the majority of 
Canr mutations in ynk1∆ strain are consistent with the mutation spectrum in 
msh2∆ mutants, changing from single nucleotide mis-incorporations and 
single/double-base frameshift events. Also, ynk1∆ msh2∆ mutants display a 
small additive effect on the generation of mutations. This evidence suggests 
that YNK1 is possibly involved in the mismatch repair pathway, exercising 
mispaired bases as a redundant 3’-5’ exonuclease in response to DNA 
damage.           
        The YNK1 amino acid sequence is highly homologous to NM23-H1, 
which suggests that NM23-H1 could also function as an anti-mutator and play 
an important role in mutations avoidance in humans, although direct evidence 
about the impact of NM23 expression on mutation rate in mammalian cells is 
lacking at present.  Consistent with the putative DNA repair function of NM23-
H1 is our observation of accumulation of NM23 within subnuclear foci 
following treatment with the DNA damaging agents etoposide, cisplatin and 
UV radiation. Collectively, these lines of evidence strongly support our 
hypothesis that NM23-H1 plays a critical role in maintaining genomic integrity 
in the tumor cells, reducing the accumulation of mutations during tumor 
metastasis pathway. Together, this study contributes to our understanding of 
the mechanisms underlying the metastasis suppressor activity of NM23-H1.  
 
 
Copyright © Mengmeng Yang 2008 
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CHAPTER FIVE 
GENERAL DISCUSSION 
 
5.1. Conclusions and Discussion 
       
        Genetic instability results in a global increased mutation rate in a cell, 
which is termed “mutator phenotype”. This idea was applied to carcinogenesis 
in 1976 by Nowell, who suggested that genetically unstable cells produce 
“successful” mutant clones for malignant process during tumor evolution 
(Nowell, 1976). In other words, the accumulated genetic changes during 
tumor progression might lead to an increasingly aggressive phenotype and 
metastasis ultimately. Since the fidelity of DNA synthesis and DNA repair play 
important roles in maintaining genomic integrity, loss of these functions 
increase genomic instability and enhance cancer risk (Sieber et al., 2003). 3’-
5’ exonucleases have an essential role in DNA replication and DNA repair by 
excising mismatched or modified nucleotides to maintain genomic integrity. At 
least 11 human proteins have been reported to exhibit 3’-5’ exonuclease 
activity, which are either associated with polymerase (for instance, 
polymerases γ, δ and ε) or autonomous (such as, TREX1, TREX2, RAD1, 
RAD9, MRE11, APE1, p53 and VDJP) (Shevelev and Hubscher, 2002). 
Defects in the proofreading activity of the 3’-5’ exonucleases could cause 
dramatic consequences in a cell. For instance, -1- a defective proofreading 
function of an autonomous 3’-5’ exonuclease (dnaQ) in E. coli led to cell 
inviability due to excessive error rates (Fijalkowska and Schaaper, 1996). -2- 
A strong mutator phenotype in S. cerevisiae was induced owing to deficient 
proofreading in combination with defective mismatch repair (Morrison et al., 
1993). -3- The loss of polymerase δ proofreading function can even lead to 
cancer in mice (Goldsby et al., 2001). Taken together, these data indicate that 
the 3’-5’ exonucleases play important roles in decreasing the mutation 
frequency and possibly inhibiting the tumorgenicity and metastatic potential. 
        NM23-H1, the first metastasis suppressor, has been recently identified to 
possess 3’-5’ exonuclease activity by our laboratory (Ma et al., 2004).  NM23 
proteins exhibit multiple enzymatic activities, consistent with its multiple 
functions in many aspects of cell signaling. Currently, at least three distinct 
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enzymatic activities of NM23-H1 are under active investigations for the 
relevant mechanism underlying metastasis-suppressing effects of NM23-H1. 
The 3’-5’ exonuclease activity of NM23-H1 represents a very plausible 
candidate, as other well known 3’-5’ exonucleases are indeed implicated in 
mechanisms of DNA repair. Moreover, the NDPK activity should also be 
considered, in light of its potential role in maintaining balance in nucleotide 
pool sizes. However, the histidine kinase activity of NM23-H1 might not be 
relevant, since this apparent protein kinase activity could be an artifact 
resulting from the presence of contaminating [γ-32P]ATP. The details will be 
discussed later in this chapter.  
        Some evidence has been collected to suggest a role of NM23-H1 in DNA 
repair. First, our laboratory has observed that nuclear translocation and 
nuclear foci formation of NM23 proteins were responsive to DNA damaging 
agents cisplatin and etoposide (Kaetzel et al., 2006). This is a typical 
phenotype of DNA repair responses. Second, our laboratory has also 
observed that multiple DNA repair genes (Rad51, HUS1, MLH1, BRCA1, 
PCNA, FEN1, DNA polymerase θ and methyl-CpG binding protein) were 
coordinately downregulated in two metastatic cell lines with NM23-H1 
overexpression (Kaetzel et al., 2006). This observation reflects that genomic 
instability is associated with the NM23-deficient state. Third, the mutator 
phenotype in NDPK-null E. coli (Lu et al., 1995) provided a direct evidence for 
a potential anti-mutator activity in a prokaryotic cell. Based on such evidence, 
some important questions arose to us: Does the 3’-5’ exonuclease activity 
mediate the metastasis suppressor activity of NM23-H1? If so, what specific 
mechanism is involved? Is DNA repair activity involved in the anti-metastatic 
function of NM23-H1? And, what kind of DNA repair pathway is regulated?  
        To address these important issues, a panel of NM23-H1 mutants with 
selective enzymatic lesions have been constructed, characterized and 
expressed in human melanoma cell lines. The transfected melanoma cells 
have been conducted metastasis assays in vitro and in vivo. In addition, the 
role of YNK1 (the yeast homologue of NM23) in DNA repair and maintenance 
of genomic integrity has been assessed by measuring the impact of ablation 
of the YNK1 gene on mutation rates in S. cerevisiae. Hopefully these studies 
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will contribute to a further understanding of the anti-metastatic functions of 
NM23-H1. 
 
5.1.1. Site-directed mutagenesis identifies Glu5 and Lys12 are necessary 
for the 3’-5’ exonuclease activity of the metastasis suppressor NM23-H1 
 
        To study the biochemical activity of NM23-H1 in metastasis suppression, 
our laboratory initiated the site-directed mutagenesis assay of NM23-H1. 
Previous results have shown that K12Q-H1 mutant lost both NDP kinase and 
3’-5’ exonuclease activities, and H118F-H1 mutant only inhibited NDP kinase 
activity  (Ma et al., 2004). In this study, we demonstrated that both K12Q and 
H118F mutants also disrupted the histidine kinase activity. In addition, to 
completely develop a panel of NM23-H1 mutants for characterization of the 3’-
5’ exonuclease active site and identification of the relevant enzymatic 
activities to the metastasis suppressor funciton, more residue substitutions of 
NM23-H1 have been generated in this study. Previously, the K12Q mutant was 
the only variant deficient in 3’-5’ exonuclease activity. In this study, we 
identified that the E5A mutant also significantly disrupted the 3’-5’ 
exonuclease activity of wild-type-H1 without markedly affecting other 
enzymatic activities. As the only variant selectively deficient in the 
exonuclease activity, E5A has the potential to provide insights into this 
enzymatic activity in DNA repair. Although both Glu5 and Lys12 are required for 
the 3’-5’ exonuclease activity of NM23-H1, whether they might be coordinate 
for the enzymatic activity is not known yet. However, they are at opposite 
ends of β1 sheet, suggesting that the β1 sheet of NM23-H1 is important in 
binding and cleaving DNA substrate. 
         
5.1.2. The histidine kinase activity of NM23-H1 might be artifactual  
 
        In the histidine protein kinase assay (performed by Robert McCorkle), 
NM23-H1 proteins were autophosphorylated at the residue His118 by 
incubation with [γ-32P]ATP, and the unbound ATP was diluted and rinsed off 
by successive rounds of ultrafiltration. Then the phosphorylated NM23-H1 
was subsequently incubated with NM23-H2, the target protein of this assay. 
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The phospho-NM23-H2 was visualized by gel electrophoresis and 
phosphorimaging. A coordinate reduction in both NDPK and hisK activities 
was shown among all of the mutants K12Q, Y52A, P96S, and H118F. This is 
difficult to explain, as the binding pockets for such disparate kinase substrates 
(nucleoside diphosphates versus proteins) should be quite different. An 
alternative explanation posed by Postel (Levit et al., 2002) is that the apparent 
protein kinase activity of NM23-H1 may be an artifact resulting from the 
presence of trace amounts of [γ-32P]ATP in the reaction mixtures. This 
contaminating [γ-32P]ATP could come from the produced ADP that is recycled 
by the nucleoside diphosphate kinase reaction. Thus, phosphorylation of the 
target protein (NM23-H2) is not a result of direct phosphotransfer from the 
phospho-NM23-H1 but rather a consequence of generation of [γ-32P]ATP from 
the produced ADP. Since nanomolar concentrations of contaminating ADP 
can trigger the phosphotransfer cascade (Levit et al., 2002), the 
contaminating ATP is not easily detected. In this experiment, the unbound 
ATP represents less than 5% of that bound to NM23-H1. The contaminating 
ATP may function more as a catalyst in this phosphotransfer cascade than a 
donor supplying the phosphoryl groups. Since this histidine kinase assay was 
conducted in parallel with the metastasis assay, we did not realize this 
possibility at the time we performed the metastasis assay. However, this 
finding indicates that the previously proposed role of the histidine kinase 
activity in mediating the metastasis suppressor activity of NM23-H1 
(Hartsough et al., 2002) may need to be reexamined. 
 
5.1.3. 3’-5’ exonuclease activity of NM23-H1 is necessary to suppress in 
vivo spontaneous metastasis  
 
        To identify the relevant enzymatic activity to the metastasis suppression 
of NM23-H1, our laboratory has initiated the lung metastasis assay using 
1205Lu cells stably transfected with NM23-H1 in nude mice. 1205Lu 
melanoma cells are suitable for this experiment due to its characteristics of 
high malignance with low background of NM23 expression. The spontaneous 
metastasis assay recapitulates most of the steps of cancer metastasis from 
primary tumor formation to metastatic lesion, representing the most powerful 
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model for studying metastasis. In the spontaneous metastasis assay, NM23-
H1 transfected melanoma cells were subcutaneously injected into 
experimental mice. After the primary tumors were removed, mice were 
continually raised for another 3 months to form lung metastases. 
        Although 1205Lu cells are highly malignant, the spontaneous lung 
metastases still need long time (3 months) to complete. Since the cells are 
human-derived, they need acquire some genetic changes to adapt to their 
new mouse environment after they are injected subcutaneously. In this study, 
we observed that the wild-type NM23-H1 significantly inhibit the spontaneous 
lung metastasis of 1205Lu melanoma cells without affecting the growth of 
primary tumor. In the primary tumors of 1205Lu cells, genomic instability is 
associated with NM23-deficient stage. In light of our microarray data, some 
DNA repair genes such as Rad51, HUS1, MLH1, BRCA1 and FEN1 might be 
upregulated at H1-deficient primary sites. The DNA repair-like activity of 
NM23-H1 might oppose the genetic instability of the 1205Lu cells, thereby 
decreasing their spontaneous metastatic potential. Also it is recently reported 
that some genes involved in motility and anchorage independent growth 
(EDG2) are downregulated by NM23-H1 (Horak et al., 2007), supporting a 
role of NM23-H1 in suppressing early stage of metastasis. In the experimental 
metastasis models, since large numbers of 1205Lu cells are introduced 
directly into the vein, the cells have omitted the early rate-limiting steps of 
metastasis. Therefore, the metastasis-suppressing effect of NM23 is absent in 
the tail-vein injected mice. These results indicate that NM23-H1 may exert the 
suppressive effects on the earlier steps of metastases by inhibiting genomic 
instability at the primary sites.         
          In this study, site-directed mutageneses of NM23-H1 (E5A-H1 and 
K12Q-H1) demonstrate that 3’-5’ exonuclease activity is necessary to suppress 
the spontaneous metastatic potential of 1205Lu melanoma cells. Originally, 
we hypothesized that the histidine kinase activity was not required for the 
metastasis suppressor function of NM23-H1 since the hisK-deficient mutation 
(P96S) still maintained a significant anti-metastatic capacity. However, as 
discussed above, we gradually realized that the histidine kinase activity of 
NM23-H1 might be artifactual. The reason for why P96S-H1 did not lose the 
metastasis-suppressing function is that P96S-H1 still possesses significant 3’-
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5’ exonuclease activity. This further supports the necessities of the 3’-5’ 
exonuclease activity for metastasis suppressor function of NM23-H1.  
        Interestingly, similar to the pattern observed in the metastasis assay, 
K12Q but not P96S mutant lost the effects of anti-metastatic progression 
exhibited by wild-type-H1 (Qingbei Zhang, Ph.D. dissertation 2006). This 
evidence further indicates that 3’-5’ exonuclease activity is required to 
suppress the metastatic progression of melanoma cells. The effects of E5A on 
the anti-metastatic progression would address the relevance of the 3’-5’ 
exonuclease activity further, while the investigation (performed by Marián 
Novak) is currently underway.  
 
5.1.4. The metastasis suppressor NM23-H1 is required for DNA repair  
 
        As known 3'-5' exonucleases are generally required for maintenance of 
genomic integrity, DNA repair activity represents a logical cellular function for 
the nuclease activities of NM23-H1 and NM23-H2. A previous study in E. coli 
provided an early indication that the NM23 homologue, ndk, was required for 
maintaining genomic integrity (Lu et al., 1995). However, the exact enzymatic 
activity(s) of ndk required for antimutator activity was not identified directly in 
that study. To measure the contribution of NM23-H1 to DNA repair, we have 
initiated experiments in the yeast Saccharomyces cerevisiae. The well-
recognized characterizations of DNA repair pathways and mechanisms in 
yeast cell provide it an excellent genetic model to determine the role of NM23 
proteins in DNA repair.  
        In this study, we have examined the contributions of YNK1, the yeast 
NM23 homologue, to genomic integrity in S. cerevisiae. Mutation rates were 
measured in a haploid YNK1 knockout (ynk1∆) strain using the standard 
CAN1 forward mutation assay. Disruption of the YNK1 gene in a haploid 
strain had no effect on viability, growth rate, spore formation, mating ability 
and morphology (Fukuchi et al., 1993). In this study, although the YNK1 
deletion had no effect on spontaneous mutation rate relative to wild-type, 
significantly increased mutations were observed in the ynk1∆ strain following 
treatment with UV radiation. These results suggest that YNK1 deletion leads 
to a significant repair deficiency to UV-induced DNA damage. Mutation 
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spectra demonstrate the most UV-induced mutations in ynk1∆ strain are base 
substitutions and frameshifts. The high conservation between YNK1 and 
NM23-H1 further indicates an anti-mutator function for the human homologue. 
The possible pathways could be: NM23 is directly involved in the repair 
process by recognizing, binding and excising modified or mutant DNA; NM23 
interacts with other DNA repair mediators; NM23 regulates other gene 
expressions which are required for maintaining genomic integrity.  
To identify possible interactions of YNK1 with other DNA repair 
mediators, additional lesions were introduced into a variety of known DNA 
checkpoints and DNA repair genes (DDC1, RAD17, MEC3, RAD27 and 
MSH2) in the ynk1∆ background. The ability of YNK1 to oppose UV-induced 
mutagenesis was negated in ynk1∆ ddc1∆, ynk1∆ rad17∆ and ynk1∆ mec3∆ 
double mutants, suggesting YNK1 is not likely to be involved in the 9-1-1 
clamp-regulated pathway. However, the ynk1∆ msh2∆ strain exhibited an 
additive effect of the two deletions on UV-induced mutation rate, with a 
mutational spectrum of nucleotide misincorporations and single/double-base 
frameshifts events in the msh2∆ strain consistent with that of ynk1∆. Taken 
together, these observations suggest involvement of YNK1 in mismatch repair 
processes.  
        There are some DNA repair pathways that NM23 protein might be 
involved: 1) Based on the formation of a Schiff-base intermediate in NM23-H2, 
the residue Lys12 of NM23-H2 has been indicated to play a DNA 
glycosylase/lyase-like role (Postel et al., 2000). The Lys12 is a highly 
conserved residue, which is necessary for both NM23-H1 and NM23-H2 in 
their DNA cleavage activity. Since DNA glycosylase activity is a signature of  
base excision repair (BER), NM23 may play a role in BER in which the ε-
amino group of lysine acts as a critical nucleophile in DNA cleavage reaction 
(Nash et al., 1997). 2) NM23 might be involved in mismatch repair pathway, 
since the deletion of YNK1 and MSH2 cause an additive phenotype of 
mutations following treatments of UV radiation with same mutational spectrum. 
3) Upon the evidence that UV insult induces nuclear translocation and nuclear 
foci formation of NM23 proteins (Kaetzel et al., 2006), and that yeast cells 
lacking functional YNK1 exhibits defective repair of UV damage, NM23 might 
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play a role in repairing UV-damaged DNA in nucleotide excision repair 
pathway.  
 
        In a summary, evidence is accumulating across a wide range of 
prokaryotic and eukaryotic organisms in support of a role for NM23-H1 in 
maintaining genomic integrity. Since NM23-H1 possesses multiple enzymatic 
activities, the mechanisms of action could be: 1) the 3’-5’ exonuclease activity 
may play an important role in DNA repair, especially under genotoxic stress. 2) 
The 3’-5’ exonuclease activity might excise a misincorporated nucleotide 
during DNA replication. 3) The NDPK activity maintains nucleotides balance, 
which might facilitate the fidelity of DNA polymerase by providing balanced 
nucleotides. Therefore, during tumor evolution, NM23 is necessary to reduce 
the generation and accumulation of mutations, by which it may inhibit cancer 
cells to acquire more genetic instability for metastatic development.    
        The eventual aim of this study is to utilize the metastasis suppressor 
NM23-H1 in the clinical setting as new therapeutic targets. To this end, our 
understandings that DNA repair activity of NM23-H1 is involved in its anti-
metastatic mechanisms may contribute to new drug discoveries. For instance, 
metastasis may be suppressed or delayed by restoring the expression of 
NM23-H1, especially its 3’-5’ exonuclease activity. The increased levels of 
DNA repair would result in a decrease in the accruement of mutations during 
metastasis progression, thereby reducing the metastasis incidence.  
 
 
5.2. Future Perspectives 
 
5.2.1. To measure the impact of NM23-H1 expression on mutation rates 
in mammalian cells.  
 
        The mutation rate is increased in Ndk-null E. coli and ynk1∆ S. 
cerevisiae strains, suggesting genes Ndk and YNK1 (NM23 homologues) play 
important roles in opposing mutations. The yeast experimental paradigm of 
this project needs to be performed on NM23-deficient mammalian cells to test 
the role of NM23 as a guardian of genome integrity in mammalian cells. 
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Mouse embryo fibroblasts (MEFs) from NM23-M1 knockout mice are available 
in our lab. So, firstly, mutation rates at the hypoxanthine phosphribosyl-
transferase (hprt) locus will be compared between MEFs derived from wild-
type and NM23-M1 knockout mice under basal conditions. Toxic nucleoside 
analog 6-thioguanine (6-TG) will be used to select hprt mutant cell. Cells 
without the hprt mutation are poisoned by 6-TG, while mutant cells survive 
and form colonies. A known numbers of cells will be seeded in medium 
containing 6-TG to detect mutant cells, and medium without 6-TG can be 
used to obtain a plating efficiency. Mutant frequency is derived from the 
number of mutant colonies in selective medium and the number of colonies in 
non-selective medium (Glaab and Tindall, 1997). Mutation rates will also be 
compared under conditions of genotoxic stress. Etoposide and UV radiation 
can be firstly chosen to treat MEFs, since we have observed that -1- these 
two treatments induced translocation of NM23 proteins to subnuclear foci. -2- 
YNK1 played an important role in UV damaged DNA response. There 
evidences suggest that genomic integrity would be compromised following 
treatment of UV radiation in NM23 deficient cells. Secondly, the degree of 
correlation between NM23-H1 status and mutation rate need to be determined 
in human melanoma cell lines. 1205Lu melanoma cells need to be examined 
due to the high malignancy and NM23 low background of the cells. The 
mutation rates can be measured under basal condition and genotoxic insult at 
the hprt locus, as described above. Or to circumvent the polyploidy of hprt 
gene, the mutation rates of 1205Lu cells can be also measured at Na+/K+ 
ATPase locus for ouabain resistant (OuaR) mutations, as described previously 
(Elmore and Barrett, 1982). Thirdly, to identify the relevant biochemical 
activity of NM23-H1 mediating its anti-mutation function, mutator phenotype of 
NM23-M1 knockout MEFs and 1205Lu cells will be complemented with wild-
type or mutant (E5A, K12Q, P96S and H118F) NM23-H1. The complementary 
effects with NM23 variants will be related to their specific activities (NDPK 
and/or 3’-5’ exonuclease).  
 
5.2.2. To measure the extent to which deletion of YNK1 affects a 
mismatch repair  
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        To directly assess whether an ablation of YNK1 causes a defect in 
mismatch repair (MMR), wild-type, ynk1∆, msh2∆ and ynk1∆ msh2∆ strains 
will be transformed with an A:C mismatch-containing plasmid. Since the A:C 
mismatch resides in an ADE8 gene, ADE8 genes in the aforementioned 
strains need to be inactivated as previously described (Tishkoff et al., 1997) 
before plasmid transformation. The plasmid carries a functional URA3 gene, 
so the transformants can be selected on SC-uracil plates. If the mismatch is 
corrected prior to DNA replication, the resulting colony is nonsectored and 
either red or white. However, if the mismatch is not repaired, then the two 
ADE8 alleles segregate after DNA replication, resulting in a red/white 
sectored colony. The proportion of sectored colonies will positively reflect an 
extent of MMR defect. In the wild-type strain, only a small number of plasmids 
escape repair, yielding sectored colonies. The msh2 mutant will be expected 
to yield about 60% of sectored colonies as previous described (Chen et al., 
1999; Luhr et al., 1998). The impacts of the disruption of YNK1 on MMR and 
the potentiating effects to MSH2 gene will be reflected by the proportion of 
red/white sectored colonies in ynk1∆ and ynk1∆ msh2∆ strains respectively. 
This approach effectively examines the impacts of ynk1 mutant on MMR 
defects in vivo. 
 
 
 
 
 
 
 
 
 
 
 
Copyright © Mengmeng Yang 2008 
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